data_1hls_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hls _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.541 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 14.8 tt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.305 0.574 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD1' HD22 ' B' ' 15' ' ' LEU . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CG ' HD23 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' B' ' 26' ' ' TYR . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.462 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.521 ' CE1' HD21 ' B' ' 11' ' ' LEU . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD13 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.531 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 2' ' ' ILE . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.65 ' CE2' ' CD1' ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.531 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.571 HD23 ' CD2' ' A' ' 19' ' ' TYR . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.553 ' CD1' HD13 ' B' ' 15' ' ' LEU . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.531 ' CD1' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.476 ' SG ' ' CD1' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.509 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 14' ' ' TYR . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CD2' HD23 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.509 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.522 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.426 ' O ' HG11 ' B' ' 12' ' ' VAL . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.552 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.1 p80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.555 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.536 ' CD1' HD21 ' A' ' 16' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB3' HD12 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD23 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.487 HD13 ' O ' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 16' ' ' LEU . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' B' ' 11' ' ' LEU . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.509 HG13 ' CE1' ' B' ' 5' ' ' HIS . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' B' ' 15' ' ' LEU . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.509 ' CE1' HG13 ' A' ' 10' ' ' ILE . 26.9 m80 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.606 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' B' ' 27' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' A' ' 19' ' ' TYR . 13.0 pt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.462 0.649 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.537 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' B' ' 15' ' ' LEU . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 1.4 mm100 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.537 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' B' ' 6' ' ' LEU . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.545 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.54 ' CD2' HD23 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 16' ' ' LEU . 6.9 tt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.405 0.622 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.507 HG11 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.495 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' CB ' HG11 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.465 HG22 ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB3' HD12 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CG ' HD23 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.465 ' O ' HG22 ' A' ' 10' ' ' ILE . 5.3 mm100 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.445 ' ND1' HG12 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.498 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.498 ' CA ' ' HB3' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.47 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 19' ' ' TYR . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.27 0.557 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HA ' HG22 ' A' ' 8' ' ' THR . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 4' ' ' GLU . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' B' ' 18' ' ' VAL . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.56 ' CD2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' HB ' ' A' ' 2' ' ' ILE . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.487 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.525 HD21 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.4 p80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 13' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.486 ' OH ' HG21 ' A' ' 3' ' ' VAL . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 8.5 pt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.465 HG21 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.477 ' HB2' HD13 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 2' ' ' ILE . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.501 ' CB ' ' HG ' ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.9 p80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB2' HD13 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 HD22 ' CD1' ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.455 ' HE2' ' HB ' ' A' ' 2' ' ' ILE . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.416 HG11 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.588 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.404 HG12 ' HG2' ' A' ' 17' ' ' GLU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.504 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.415 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 15' ' ' GLN . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CG ' HD23 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.443 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.515 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.625 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.169 0.509 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' CB ' HD13 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' B' ' 15' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CE1' ' HB ' ' A' ' 2' ' ' ILE . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.495 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.546 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.432 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.592 ' CD2' HG21 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' B' ' 11' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.527 ' CG2' ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.444 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 9' ' ' SER . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.423 ' O ' HG12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 9' ' ' SER . 8.5 m80 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.53 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.539 ' CD2' HD12 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.468 ' O ' HG21 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.647 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 13' ' ' LEU . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.647 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 16' ' ' LEU . 3.9 tt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.255 0.55 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 5' ' ' GLN . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' C ' HD12 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' B' ' 14' ' ' ALA . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.539 ' O ' ' CB ' ' B' ' 24' ' ' PHE . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.399 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 7' ' ' CYS . 23.9 m80 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.507 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.507 ' CA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.54 ' CG2' HD12 ' B' ' 11' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.531 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 12' ' ' SER . 19.3 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD11 HD22 ' B' ' 15' ' ' LEU . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CG ' HD23 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.348 0.595 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.483 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.54 HD12 ' CG2' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.568 HD23 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.569 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' B' ' 27' ' ' THR . 15.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.547 ' CG2' HD12 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG21 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.47 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' PHE . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 2.1 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.47 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.547 HD12 ' CG2' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.56 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.549 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.544 ' N ' HG21 ' A' ' 2' ' ' ILE . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.497 ' HB2' HD13 ' B' ' 11' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.493 HG22 HD11 ' A' ' 10' ' ' ILE . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' B' ' 14' ' ' ALA . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HA ' HG13 ' B' ' 18' ' ' VAL . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CD1' HD23 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.546 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.644 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.573 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.8 p80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.51 HG23 ' CD1' ' A' ' 13' ' ' LEU . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.538 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.58 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.53 HD23 ' CG2' ' A' ' 2' ' ' ILE . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' B' ' 26' ' ' TYR . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.616 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.582 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 13' ' ' LEU . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.53 ' HB ' ' HE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.423 ' C ' HD12 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.541 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' B' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.56 HD12 ' CE2' ' A' ' 19' ' ' TYR . 7.9 pt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.456 0.646 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HD11 ' A' ' 10' ' ' ILE . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 2' ' ' ILE . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.526 ' CB ' ' HG ' ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.512 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.477 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.6 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.536 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.541 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 14.8 tt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -1.032 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD1' HD22 ' B' ' 15' ' ' LEU . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CG ' HD23 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.38 151.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -62.84 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -138.08 152.83 49.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.521 HD21 ' CE1' ' B' ' 26' ' ' TYR . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.462 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.521 ' CE1' HD21 ' B' ' 11' ' ' LEU . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.49 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.3 t -127.54 57.92 28.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.4 Cg_endo -62.94 -168.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.332 2.688 . . . . 0.0 110.183 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -150.99 -38.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 109.697 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.29 19.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -1.055 . . . . 0.0 109.223 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD13 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' CD2' HG13 ' A' ' 2' ' ' ILE . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.65 ' CE2' ' CD1' ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 93.5 t -158.52 116.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -71.76 110.03 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 109.5 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -147.09 156.12 42.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.531 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.498 HG11 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.571 HD23 ' CD2' ' A' ' 19' ' ' TYR . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.565 ' CD2' ' HD3' ' B' ' 28' ' ' PRO . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.58 68.21 52.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 4.4 Cg_exo -58.95 116.17 3.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.382 2.721 . . . . 0.0 110.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -116.06 88.86 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.451 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.488 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.531 ' CD1' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -61.07 -37.81 78.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.513 -0.992 . . . . 0.0 108.785 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.476 ' SG ' ' CD1' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.509 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 14' ' ' TYR . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CD2' HD23 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.527 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 92.3 t -158.8 141.51 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.471 ' N ' HG11 ' B' ' 2' ' ' VAL . 0.6 OUTLIER -70.73 98.41 1.53 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.561 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' B' ' 2' ' ' VAL . 10.6 mt-30 -140.63 148.67 41.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.41 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.509 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.416 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.522 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.426 ' O ' HG11 ' B' ' 12' ' ' VAL . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.552 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.1 p80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.565 ' CD2' ' HG3' ' B' ' 28' ' ' PRO . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -123.55 70.36 45.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.565 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.1 Cg_endo -61.69 108.7 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.299 2.666 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.416 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.377 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.536 ' CD1' HD21 ' A' ' 16' ' ' LEU . 4.4 tt -90.35 -30.24 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' B' ' 3' ' ' ASN . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB3' HD12 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD23 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.227 0.537 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.31 156.89 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.326 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.469 ' HB3' HD11 ' A' ' 10' ' ' ILE . 3.7 m-20 -100.35 114.11 27.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.518 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -146.86 160.33 42.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.487 HD13 ' O ' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 16' ' ' LEU . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 67.02 69.88 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 2.2 Cg_endo -61.13 90.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.463 2.775 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.2 83.07 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.428 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.84 8.37 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 109.196 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.49 ' HB2' HD13 ' B' ' 11' ' ' LEU . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.509 HG13 ' CE1' ' B' ' 5' ' ' HIS . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' B' ' 15' ' ' LEU . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.555 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 84.5 t -160.08 132.29 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -61.43 107.83 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.642 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.81 152.31 31.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.509 ' CE1' HG13 ' A' ' 10' ' ' ILE . 26.9 m80 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.606 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -131.52 57.99 34.81 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.54 103.73 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.36 2.707 . . . . 0.0 109.986 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.63 86.25 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.418 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' A' ' 19' ' ' TYR . 13.0 pt -90.29 -25.03 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.537 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' B' ' 15' ' ' LEU . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' OE1' ' CG ' ' A' ' 14' ' ' TYR . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' HD12 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.32 155.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.436 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 44.0 p-10 -94.02 84.11 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.436 ' HG2' ' C ' ' B' ' 3' ' ' ASN . 1.4 mm100 -130.54 -160.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.537 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.54 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.54 ' HG ' ' CD1' ' B' ' 6' ' ' LEU . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.545 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.54 ' CD2' HD23 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.516 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -128.51 56.35 21.98 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.1 Cg_endo -60.38 -170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.239 2.626 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -76.0 171.3 14.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.547 HD12 ' CD2' ' A' ' 16' ' ' LEU . 6.9 tt -90.66 -11.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.633 -0.922 . . . . 0.0 109.642 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.507 HG11 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.495 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' CB ' HG11 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.465 HG22 ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB3' HD12 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CG ' HD23 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.587 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.41 0.624 . . . . 0.0 109.605 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.96 137.52 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -77.51 92.36 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.336 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.465 ' O ' HG22 ' A' ' 10' ' ' ILE . 5.3 mm100 -135.03 -177.44 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.445 ' ND1' HG12 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.498 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.498 ' CA ' ' HB3' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.47 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 16' ' ' LEU . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 19' ' ' TYR . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.34 73.71 50.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.493 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -60.23 117.37 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.355 2.703 . . . . 0.0 110.003 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 101.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.421 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.5 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' B' ' 27' ' ' THR . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt -90.46 -5.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.368 -1.078 . . . . 0.0 110.032 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG21 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HA ' HG22 ' A' ' 8' ' ' THR . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 4' ' ' GLU . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' B' ' 18' ' ' VAL . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.56 ' CD2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CE2' ' HB ' ' A' ' 2' ' ' ILE . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' B' ' 1' ' ' PHE . 37.9 t80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 91.2 t -159.23 135.71 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -60.03 101.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.399 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -149.02 177.9 9.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.487 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.525 HD21 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.4 p80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 13' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.526 ' CD2' ' HD3' ' B' ' 28' ' ' PRO . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.458 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.4 t -126.63 58.61 28.53 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -57.61 -170.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.323 2.682 . . . . 0.0 110.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' B' ' 29' ' ' LYS . 6.7 ttmm -151.27 47.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.473 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.59 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 8.5 pt -84.84 -36.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.465 HG21 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.477 ' HB2' HD13 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.4 HD12 ' C ' ' B' ' 3' ' ' ASN . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 2' ' ' ILE . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.43 ' CE1' HD22 ' B' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.79 141.54 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' B' ' 4' ' ' GLN . 12.6 m120 -71.71 85.93 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' B' ' 3' ' ' ASN . 1.3 mm100 -144.5 132.36 21.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 109.567 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.501 ' CB ' ' HG ' ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.9 p80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -135.04 67.18 69.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.02 82.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.41 2.74 . . . . 0.0 109.891 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.49 171.62 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.519 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.43 -42.91 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.488 -1.007 . . . . 0.0 108.904 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB2' HD13 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD22 ' CD1' ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.455 ' HE2' ' HB ' ' A' ' 2' ' ' ILE . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 1.4 p90 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.257 0.551 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.2 125.83 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.341 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -96.91 128.64 44.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.674 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -115.92 -171.29 1.95 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.416 HG11 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.607 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.588 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.404 HG12 ' HG2' ' A' ' 17' ' ' GLU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.569 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -126.87 51.38 6.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.7 Cg_endo -61.42 118.62 5.5 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.072 2.515 . . . . 0.0 109.681 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.93 144.62 43.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.768 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.372 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.504 ' CD1' HD21 ' A' ' 16' ' ' LEU . 1.5 tt -68.45 -32.88 57.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.534 -0.98 . . . . 0.0 109.455 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.415 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 15' ' ' GLN . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' CG ' HD23 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.56 129.76 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.575 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.463 ' O ' ' OD1' ' B' ' 3' ' ' ASN . 17.1 p30 -79.61 87.52 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 -141.61 154.42 45.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.443 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.515 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m -136.5 66.44 57.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.554 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -59.6 -176.14 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.447 2.765 . . . . 0.0 110.163 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -136.12 49.29 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.408 HG21 ' OXT' ' B' ' 30' ' ' THR . 20.5 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.625 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -90.58 -0.31 9.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.39 -1.065 . . . . 0.0 109.934 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.525 ' CB ' HD13 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' B' ' 15' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CE1' ' HB ' ' A' ' 2' ' ' ILE . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.489 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 60.3 t -157.19 123.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -64.15 92.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 109.666 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -136.41 165.18 26.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.495 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.546 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.592 HG21 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.432 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.592 ' CD2' HG21 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 76.63 7.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.446 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 5.2 Cg_exo -59.01 -170.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.353 2.702 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 178.52 4.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 109.571 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' B' ' 11' ' ' LEU . 0.1 OUTLIER -90.41 -9.84 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -1.154 . . . . 0.0 109.222 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.527 ' CG2' ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.444 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 9' ' ' SER . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.278 0.561 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.52 147.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' B' ' 3' ' ' ASN . 6.5 p-10 -77.69 79.33 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.423 ' O ' HG12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -116.92 -161.41 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.116 -0.99 . . . . 0.0 109.476 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 9' ' ' SER . 8.5 m80 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.53 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.539 ' CD2' HD12 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.468 ' O ' HG21 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.647 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 13' ' ' LEU . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.647 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.7 OUTLIER -133.34 59.18 39.38 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' B' ' 27' ' ' THR . 3.1 Cg_endo -66.52 135.07 37.82 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.351 2.701 . . . . 0.0 109.815 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -114.3 107.52 15.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 16' ' ' LEU . 3.9 tt -90.63 -6.13 10.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.612 -0.934 . . . . 0.0 109.538 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 5' ' ' GLN . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' C ' HD12 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' B' ' 14' ' ' ALA . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' O ' ' CB ' ' B' ' 24' ' ' PHE . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.284 0.564 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.83 153.75 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -104.79 113.57 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.73 -151.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 7' ' ' CYS . 23.9 m80 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.507 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.507 ' CA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 13' ' ' LEU . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.54 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 9.8 t -129.0 54.6 14.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.0 OUTLIER -61.66 96.66 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.181 2.587 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 6.6 pttp -118.26 140.52 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.66 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.54 ' CG2' HD12 ' B' ' 11' ' ' LEU . 0.3 OUTLIER -56.01 -33.55 36.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.448 -1.03 . . . . 0.0 109.213 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.531 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.526 ' CD1' HG23 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 12' ' ' SER . 19.3 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD11 HD22 ' B' ' 15' ' ' LEU . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.568 ' CG ' HD23 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 1' ' ' PHE . 12.1 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.65 171.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.415 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 1.9 m-20 -70.27 84.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -130.67 -161.04 1.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.483 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.54 HD12 ' CG2' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.568 HD23 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.569 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' B' ' 27' ' ' THR . 15.1 t -130.0 59.19 43.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.3 Cg_endo -60.08 92.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.457 2.771 . . . . 0.0 110.153 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.46 101.07 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.51 -179.818 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.547 ' CG2' HD12 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -63.6 -37.03 78.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.614 -0.933 . . . . 0.0 109.128 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG21 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.47 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' CD2' HD11 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' PHE . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 2.1 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 2' ' ' VAL . 1.4 p90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.419 0.628 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.477 ' O ' ' CE2' ' B' ' 1' ' ' PHE . 0.4 OUTLIER -79.87 107.8 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.367 -0.833 . . . . 0.0 109.187 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.29 77.44 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.15 161.29 16.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.379 -0.826 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.47 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.547 HD12 ' CG2' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.56 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.549 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.478 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.6 t -129.0 60.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.2 Cg_endo -65.24 80.71 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.304 2.669 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' B' ' 28' ' ' PRO . 18.1 mttt -149.23 -172.05 4.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.418 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' CD2' ' B' ' 11' ' ' LEU . 0.0 OUTLIER -90.36 -39.55 12.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -1.005 . . . . 0.0 109.169 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.544 ' N ' HG21 ' A' ' 2' ' ' ILE . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' HB2' HD13 ' B' ' 11' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.493 HG22 HD11 ' A' ' 10' ' ' ILE . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' B' ' 14' ' ' ALA . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HA ' HG13 ' B' ' 18' ' ' VAL . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CD1' HD23 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.89 108.78 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.46 ' O ' HD12 ' A' ' 10' ' ' ILE . 8.5 m120 -88.89 68.3 8.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.546 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.644 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.573 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.8 p80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.51 HG23 ' CD1' ' A' ' 13' ' ' LEU . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' B' ' 28' ' ' PRO . 27.6 m -123.15 48.59 2.07 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' B' ' 27' ' ' THR . 1.5 Cg_endo -60.06 -167.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.177 2.585 . . . . 0.0 110.061 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.421 ' CE ' ' CA ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -165.2 83.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.416 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.52 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -60.53 -31.39 48.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' CD1' HG23 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.667 0.746 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.461 HG11 ' N ' ' B' ' 3' ' ' ASN . 45.8 t -79.3 149.82 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.065 -1.022 . . . . 0.0 109.454 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 10' ' ' ILE . 2.5 p-10 -85.5 114.2 22.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.419 ' HG3' ' C ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER -132.9 174.12 10.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.58 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.53 HD23 ' CG2' ' A' ' 2' ' ' ILE . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' B' ' 26' ' ' TYR . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.616 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.582 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 13' ' ' LEU . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.476 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 49.1 p -129.18 60.2 49.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.52 -169.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.328 2.685 . . . . 0.0 109.962 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -111.25 35.11 3.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.214 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.516 -179.904 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.53 ' HB ' ' HE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -90.47 2.15 7.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.896 -0.767 . . . . 0.0 109.299 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.423 ' C ' HD12 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.0 132.73 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.664 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' B' ' 3' ' ' ASN . 11.4 p30 -102.26 72.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.382 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.54 167.25 10.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.509 HD23 ' CG2' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.541 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.49 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -127.45 59.03 35.14 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.6 Cg_endo -59.52 -170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.432 2.755 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -122.58 16.76 10.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.519 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.56 HD12 ' CE2' ' A' ' 19' ' ' TYR . 7.9 pt -86.78 14.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HD11 ' A' ' 10' ' ' ILE . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 2' ' ' ILE . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.32 101.11 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.406 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 23.7 p30 -97.64 75.75 2.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.406 ' HG2' ' C ' ' B' ' 3' ' ' ASN . 2.2 mm-40 -129.06 -171.79 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.837 . . . . 0.0 109.487 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.526 ' CB ' ' HG ' ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.512 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.477 ' O ' HG22 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.6 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.536 ' CG2' ' CD1' ' A' ' 13' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.54 69.19 42.77 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.08 96.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 109.806 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -119.6 28.43 8.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.667 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.487 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.8 tt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.305 0.574 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.698 HG22 ' OH ' ' B' ' 26' ' ' TYR . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.67 ' HB2' HD11 ' B' ' 11' ' ' LEU . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' HG12 ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.749 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.829 ' CB ' HG21 ' B' ' 18' ' ' VAL . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.915 ' CB ' HD22 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.525 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.915 HD22 ' CB ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.571 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 14' ' ' ALA . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.133 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 HG22 ' B' ' 18' ' ' VAL . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.568 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.944 HD22 HD21 ' B' ' 15' ' ' LEU . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' HG11 ' B' ' 18' ' ' VAL . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 1.133 ' CE2' HD12 ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.554 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' B' ' 15' ' ' LEU . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.547 HG13 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.733 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 16' ' ' LEU . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 8.6 p-80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' ' 17' ' ' LEU . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 14' ' ' ALA . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.7 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.76 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' THR . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.534 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.842 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' C ' HD11 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' HG11 ' B' ' 18' ' ' VAL . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.68 ' CB ' HD22 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.534 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.76 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.428 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.3 p-80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.403 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.842 HG22 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.657 HD11 HD23 ' A' ' 16' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.944 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.961 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CB ' HD22 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OXT' ' OD1' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.727 ' O ' HD23 ' B' ' 6' ' ' LEU . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.727 HD23 ' O ' ' B' ' 5' ' ' HIS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.625 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.582 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 16' ' ' LEU . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.625 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p-80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.944 HG22 ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.045 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.49 HG22 ' OH ' ' B' ' 26' ' ' TYR . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.995 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.822 ' HB2' HG21 ' B' ' 18' ' ' VAL . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 1.045 ' CE2' HD12 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.474 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 24.1 m-70 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.757 HD22 HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 10' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.797 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 16' ' ' LEU . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.6 p-80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.995 HG22 ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' B' ' 27' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.981 HD12 HD22 ' B' ' 11' ' ' LEU . 13.0 pt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.462 0.649 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.544 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.037 HD11 HG22 ' B' ' 18' ' ' VAL . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.884 ' CB ' HG21 ' B' ' 18' ' ' VAL . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' B' ' 18' ' ' VAL . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' CE2' HD13 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 1.4 mm100 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.544 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.981 HD22 HD12 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.504 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 1.05 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.539 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 8.6 p-80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 1.05 HG23 ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.765 ' CE1' HD11 ' A' ' 2' ' ' ILE . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD23 ' A' ' 16' ' ' LEU . 6.9 tt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.405 0.622 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.512 ' CB ' HG13 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.683 HD11 ' HE1' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.809 HD12 HG22 ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.813 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.787 ' CB ' HD22 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 mm100 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.683 ' HE1' HD11 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.511 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.709 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.81 HD23 ' HB3' ' A' ' 16' ' ' LEU . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.613 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.5 p-80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.405 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.809 HG22 HD12 ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.27 0.557 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' CYS . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB2' HG21 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CB ' HD22 ' B' ' 15' ' ' LEU . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.415 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 35.9 m-70 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' B' ' 9' ' ' SER . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.65 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.821 HD22 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.494 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 10.9 p-80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' B' ' 17' ' ' LEU . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 16' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.563 ' CD1' HD11 ' B' ' 15' ' ' LEU . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' B' ' 11' ' ' LEU . 8.5 pt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.645 ' HB2' HD11 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.679 HD21 HG22 ' B' ' 18' ' ' VAL . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.836 HD22 HD21 ' B' ' 15' ' ' LEU . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.648 ' HB2' HD22 ' B' ' 15' ' ' LEU . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.683 ' O ' HD12 ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.512 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.836 HD21 HD22 ' A' ' 16' ' ' LEU . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 8.3 p-80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.435 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.696 ' OH ' HG22 ' A' ' 3' ' ' VAL . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.772 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.566 ' HB2' HD11 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 10' ' ' ILE . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 HG22 ' B' ' 18' ' ' VAL . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' CD2' HD13 ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.604 ' HA ' HG11 ' B' ' 18' ' ' VAL . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.699 ' CB ' HD22 ' B' ' 15' ' ' LEU . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.649 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 19' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.741 HG22 HD22 ' A' ' 13' ' ' LEU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.647 HD11 HD23 ' A' ' 16' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.749 HG22 ' OH ' ' B' ' 26' ' ' TYR . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.614 ' HB2' HD11 ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.945 HD11 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' HB3' HD11 ' A' ' 2' ' ' ILE . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.938 ' HB3' HD23 ' B' ' 15' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.82 ' CB ' HD22 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 6' ' ' CYS . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.599 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 16' ' ' LEU . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.9 p-80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.435 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.749 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.169 0.509 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.519 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.881 ' CB ' HD22 ' B' ' 15' ' ' LEU . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.519 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.566 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.628 HG22 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.2 p-80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CD2' HG22 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.83 HD11 HD21 ' B' ' 11' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.848 HG22 ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 9' ' ' SER . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.953 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.617 ' HB2' HD22 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 15.1 m-70 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.787 ' HB2' HD12 ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.73 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 16' ' ' LEU . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.602 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.0 p-80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 14' ' ' ALA . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.848 ' OH ' HG22 ' A' ' 3' ' ' VAL . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 15' ' ' GLN . 3.9 tt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.255 0.55 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HB2' HD11 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.64 ' HB3' HD11 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' B' ' 18' ' ' VAL . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.59 ' CB ' HD22 ' B' ' 15' ' ' LEU . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.399 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.51 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 24.8 m-70 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.567 ' O ' HD12 ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.481 HG13 ' CE2' ' B' ' 24' ' ' PHE . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.544 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.908 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 11.1 p-80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' B' ' 17' ' ' LEU . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 14' ' ' ALA . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' B' ' 27' ' ' THR . 9.8 t . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.845 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 2' ' ' ILE . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB2' HD11 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.756 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' C ' HD11 ' A' ' 2' ' ' ILE . 25.5 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.845 ' CD2' HD13 ' A' ' 2' ' ' ILE . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.804 ' CG ' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.348 0.595 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.474 ' O ' HD23 ' B' ' 6' ' ' LEU . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.73 ' HA ' HD12 ' B' ' 15' ' ' LEU . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.804 HD22 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 8.8 p-80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 27' ' ' THR . 15.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG22 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' HB2' HD11 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.479 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.946 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.788 ' CD2' HD13 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 32.1 t30 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.479 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 6' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.638 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 16' ' ' LEU . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 9.5 p-80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.424 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.946 HG22 ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.671 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' B' ' 6' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD12 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.705 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.546 ' O ' HD23 ' B' ' 6' ' ' LEU . 21.3 m170 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.649 ' O ' HD12 ' B' ' 11' ' ' LEU . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.662 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 19' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.591 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.6 p-80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 14' ' ' ALA . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.521 ' O ' HG22 ' B' ' 27' ' ' THR . 27.6 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.86 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.889 HD11 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.86 ' CD2' HD13 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.7 ' HE2' HD12 ' A' ' 2' ' ' ILE . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.596 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' B' ' 24' ' ' PHE . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.615 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 16' ' ' LEU . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.615 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 9.8 p-80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 14' ' ' ALA . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.684 ' HB2' HD11 ' B' ' 11' ' ' LEU . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.926 HD22 HG22 ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' C ' HD11 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.935 ' HB3' HD23 ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.589 ' O ' HD23 ' B' ' 6' ' ' LEU . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.589 HD23 ' O ' ' B' ' 5' ' ' HIS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 16' ' ' LEU . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.8 p-80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.926 HG22 HD22 ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' B' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.571 HD13 ' HE2' ' A' ' 19' ' ' TYR . 7.9 pt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.456 0.646 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.518 HG22 ' OH ' ' B' ' 26' ' ' TYR . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.61 ' HB2' HD11 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.408 ' C ' HD23 ' A' ' 16' ' ' LEU . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' B' ' 18' ' ' VAL . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HE2' HD13 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.626 ' O ' HD12 ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' B' ' 24' ' ' PHE . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.467 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.46 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 16' ' ' LEU . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 17' ' ' LEU . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 16' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' B' ' 12' ' ' VAL . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.8 tt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -1.032 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.698 HG22 ' OH ' ' B' ' 26' ' ' TYR . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' HB2' HD11 ' B' ' 11' ' ' LEU . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' HG12 ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.749 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.829 ' CB ' HG21 ' B' ' 18' ' ' VAL . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.915 ' CB ' HD22 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.38 151.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -62.84 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -138.08 152.83 49.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.525 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.5 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.915 HD22 ' CB ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.571 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 14' ' ' ALA . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.3 t -127.54 57.92 28.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.4 Cg_endo -62.94 -168.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.332 2.688 . . . . 0.0 110.183 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -150.99 -38.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 109.697 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.133 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.29 19.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -1.055 . . . . 0.0 109.223 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 HG22 ' B' ' 18' ' ' VAL . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.568 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.944 HD22 HD21 ' B' ' 15' ' ' LEU . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' HG11 ' B' ' 18' ' ' VAL . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 1.133 ' CE2' HD12 ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 93.5 t -158.52 116.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.547 ' HB3' HG21 ' A' ' 10' ' ' ILE . 68.6 m-80 -71.76 110.03 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -147.09 156.12 42.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.554 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' B' ' 15' ' ' LEU . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.547 HG13 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.733 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 16' ' ' LEU . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 8.6 p-80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' ' 17' ' ' LEU . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 14' ' ' ALA . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.55 ' CD2' ' HD3' ' B' ' 28' ' ' PRO . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.58 68.21 52.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 4.4 Cg_exo -58.95 116.17 3.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.382 2.721 . . . . 0.0 110.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -116.06 88.86 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.451 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.488 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.7 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -61.07 -37.81 78.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.513 -0.992 . . . . 0.0 108.785 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.76 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' THR . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.842 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' C ' HD11 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' HG11 ' B' ' 18' ' ' VAL . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.68 ' CB ' HD22 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.527 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 92.3 t -158.8 141.51 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.421 ' C ' ' HG3' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -70.73 98.41 1.53 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.561 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.471 ' OE1' ' HB ' ' B' ' 2' ' ' VAL . 10.6 mt-30 -140.63 148.67 41.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.41 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.534 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.76 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.428 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.3 p-80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.403 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.842 HG22 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -123.55 70.36 45.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.557 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.1 Cg_endo -61.69 108.7 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.299 2.666 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.377 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.657 HD11 HD23 ' A' ' 16' ' ' LEU . 4.4 tt -90.35 -30.24 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' B' ' 3' ' ' ASN . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.944 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.961 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CB ' HD22 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OXT' ' OD1' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.227 0.537 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.31 156.89 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.326 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.615 ' HB3' HG21 ' A' ' 10' ' ' ILE . 3.7 m-20 -100.35 114.11 27.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.518 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -146.86 160.33 42.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.727 ' O ' HD23 ' B' ' 6' ' ' LEU . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.727 HD23 ' O ' ' B' ' 5' ' ' HIS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.625 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.582 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 16' ' ' LEU . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.625 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p-80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.944 HG22 ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 67.02 69.88 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 2.2 Cg_endo -61.13 90.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.463 2.775 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.2 83.07 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.449 HG23 ' O ' ' B' ' 30' ' ' THR . 9.9 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.045 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.84 8.37 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 109.196 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.49 HG22 ' OH ' ' B' ' 26' ' ' TYR . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD13 ' HB3' ' B' ' 3' ' ' ASN . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.995 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.822 ' HB2' HG21 ' B' ' 18' ' ' VAL . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 1.045 ' CE2' HD12 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.611 ' O ' HG23 ' B' ' 2' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.611 HG23 ' O ' ' B' ' 1' ' ' PHE . 84.5 t -160.08 132.29 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.402 ' HB3' HD13 ' A' ' 10' ' ' ILE . 7.8 m120 -61.43 107.83 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.642 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.81 152.31 31.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.474 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 24.1 m-70 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.757 HD22 HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 10' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.797 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 16' ' ' LEU . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.6 p-80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.995 HG22 ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.54 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -131.52 57.99 34.81 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.54 103.73 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.36 2.707 . . . . 0.0 109.986 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.63 86.25 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.418 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.981 HD12 HD22 ' B' ' 11' ' ' LEU . 13.0 pt -90.29 -25.03 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.544 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.037 HD11 HG22 ' B' ' 18' ' ' VAL . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.884 ' CB ' HG21 ' B' ' 18' ' ' VAL . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' B' ' 18' ' ' VAL . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' CE2' HD13 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.32 155.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.434 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 44.0 p-10 -94.02 84.11 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 1.4 mm100 -130.54 -160.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.544 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.981 HD22 HD12 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.504 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 1.05 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.539 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 8.6 p-80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 1.05 HG23 ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.765 ' CE1' HD11 ' A' ' 2' ' ' ILE . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -128.51 56.35 21.98 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.1 Cg_endo -60.38 -170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.239 2.626 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -76.0 171.3 14.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD23 ' A' ' 16' ' ' LEU . 6.9 tt -90.66 -11.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.633 -0.922 . . . . 0.0 109.642 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.512 ' CB ' HG13 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.683 HD11 ' HE1' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.809 HD12 HG22 ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.813 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.787 ' CB ' HD22 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.41 0.624 . . . . 0.0 109.605 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.435 ' H ' HG23 ' B' ' 2' ' ' VAL . 1.8 t -79.96 137.52 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.549 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 3' ' ' ASN . 1.7 p-10 -77.51 92.36 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.336 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 mm100 -135.03 -177.44 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.683 ' HE1' HD11 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.511 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.709 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.81 HD23 ' HB3' ' A' ' 16' ' ' LEU . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.613 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.5 p-80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.405 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.809 HG22 HD12 ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.34 73.71 50.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.479 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -60.23 117.37 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.355 2.703 . . . . 0.0 110.003 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 101.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.421 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.5 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.518 ' HA2' HG21 ' B' ' 27' ' ' THR . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt -90.46 -5.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.368 -1.078 . . . . 0.0 110.032 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' CYS . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB2' HG21 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CB ' HD22 ' B' ' 15' ' ' LEU . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.57 ' O ' ' CD2' ' B' ' 1' ' ' PHE . 37.9 t80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 1' ' ' PHE . 91.2 t -159.23 135.71 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -60.03 101.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.399 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -149.02 177.9 9.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.415 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 35.9 m-70 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' B' ' 9' ' ' SER . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.65 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.821 HD22 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.494 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 10.9 p-80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' B' ' 17' ' ' LEU . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 16' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.563 ' CD1' HD11 ' B' ' 15' ' ' LEU . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.518 HG21 ' HA2' ' A' ' 1' ' ' GLY . 1.4 t -126.63 58.61 28.53 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -57.61 -170.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.323 2.682 . . . . 0.0 110.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 6.7 ttmm -151.27 47.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.473 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' B' ' 11' ' ' LEU . 8.5 pt -84.84 -36.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.645 ' HB2' HD11 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.547 HG21 ' HA ' ' B' ' 3' ' ' ASN . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.679 HD21 HG22 ' B' ' 18' ' ' VAL . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.836 HD22 HD21 ' B' ' 15' ' ' LEU . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.648 ' HB2' HD22 ' B' ' 15' ' ' LEU . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.79 141.54 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.547 ' HA ' HG21 ' A' ' 10' ' ' ILE . 12.6 m120 -71.71 85.93 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' B' ' 3' ' ' ASN . 1.3 mm100 -144.5 132.36 21.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 109.567 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.683 ' O ' HD12 ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.512 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.836 HD21 HD22 ' A' ' 16' ' ' LEU . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 8.3 p-80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.435 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.696 ' OH ' HG22 ' A' ' 3' ' ' VAL . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -135.04 67.18 69.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.02 82.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.41 2.74 . . . . 0.0 109.891 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.49 171.62 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.519 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.772 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.43 -42.91 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.488 -1.007 . . . . 0.0 108.904 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.566 ' HB2' HD11 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 10' ' ' ILE . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 HG22 ' B' ' 18' ' ' VAL . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' CD2' HD13 ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.604 ' HA ' HG11 ' B' ' 18' ' ' VAL . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.699 ' CB ' HD22 ' B' ' 15' ' ' LEU . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.581 ' H3 ' ' HD1' ' B' ' 1' ' ' PHE . 1.4 p90 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.257 0.551 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.2 125.83 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.341 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -96.91 128.64 44.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.674 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -115.92 -171.29 1.95 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.649 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 19' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.741 HG22 HD22 ' A' ' 13' ' ' LEU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.594 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -126.87 51.38 6.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.7 Cg_endo -61.42 118.62 5.5 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.072 2.515 . . . . 0.0 109.681 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.93 144.62 43.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.768 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.372 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.647 HD11 HD23 ' A' ' 16' ' ' LEU . 1.5 tt -68.45 -32.88 57.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.534 -0.98 . . . . 0.0 109.455 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.749 HG22 ' OH ' ' B' ' 26' ' ' TYR . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.614 ' HB2' HD11 ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.945 HD11 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' HB3' HD11 ' A' ' 2' ' ' ILE . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.938 ' HB3' HD23 ' B' ' 15' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.82 ' CB ' HD22 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.56 129.76 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.575 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 3' ' ' ASN . 17.1 p30 -79.61 87.52 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 -141.61 154.42 45.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 6' ' ' CYS . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.599 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 16' ' ' LEU . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.9 p-80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.435 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.749 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m -136.5 66.44 57.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.542 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -59.6 -176.14 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.447 2.765 . . . . 0.0 110.163 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -136.12 49.29 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.406 ' OXT' HG22 ' B' ' 30' ' ' THR . 20.5 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -90.58 -0.31 9.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.39 -1.065 . . . . 0.0 109.934 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.519 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.881 ' CB ' HD22 ' B' ' 15' ' ' LEU . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.608 ' H3 ' ' HD1' ' B' ' 1' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.502 HG23 ' C ' ' B' ' 1' ' ' PHE . 60.3 t -157.19 123.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -64.15 92.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 109.666 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -136.41 165.18 26.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.519 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.566 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.628 HG22 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.2 p-80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' B' ' 1' ' ' PHE . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CD2' HG22 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 76.63 7.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 5.2 Cg_exo -59.01 -170.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.353 2.702 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 178.52 4.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 109.571 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.83 HD11 HD21 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -90.41 -9.84 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -1.154 . . . . 0.0 109.222 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.848 HG22 ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 9' ' ' SER . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.953 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.617 ' HB2' HD22 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.278 0.561 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.52 147.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' B' ' 3' ' ' ASN . 6.5 p-10 -77.69 79.33 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -116.92 -161.41 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.116 -0.99 . . . . 0.0 109.476 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.517 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 15.1 m-70 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.787 ' HB2' HD12 ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.73 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 16' ' ' LEU . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.602 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.0 p-80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 14' ' ' ALA . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.848 ' OH ' HG22 ' A' ' 3' ' ' VAL . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.7 OUTLIER -133.34 59.18 39.38 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' B' ' 27' ' ' THR . 3.1 Cg_endo -66.52 135.07 37.82 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.351 2.701 . . . . 0.0 109.815 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -114.3 107.52 15.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 15' ' ' GLN . 3.9 tt -90.63 -6.13 10.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.612 -0.934 . . . . 0.0 109.538 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HB2' HD11 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.64 ' HB3' HD11 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' B' ' 18' ' ' VAL . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.59 ' CB ' HD22 ' B' ' 15' ' ' LEU . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.284 0.564 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.83 153.75 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.79 113.57 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.73 -151.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.51 ' N ' ' CD2' ' B' ' 5' ' ' HIS . 24.8 m-70 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.567 ' O ' HD12 ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.481 HG13 ' CE2' ' B' ' 24' ' ' PHE . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.544 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.908 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 11.1 p-80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' B' ' 17' ' ' LEU . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 14' ' ' ALA . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 9.8 t -129.0 54.6 14.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.0 OUTLIER -61.66 96.66 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.181 2.587 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 6.6 pttp -118.26 140.52 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.66 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.845 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.01 -33.55 36.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.448 -1.03 . . . . 0.0 109.213 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 2' ' ' ILE . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB2' HD11 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.756 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' C ' HD11 ' A' ' 2' ' ' ILE . 25.5 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.845 ' CD2' HD13 ' A' ' 2' ' ' ILE . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.804 ' CG ' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' B' ' 1' ' ' PHE . 12.1 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.544 HG12 ' H ' ' B' ' 3' ' ' ASN . 3.9 t -103.65 171.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.544 ' H ' HG12 ' B' ' 2' ' ' VAL . 1.9 m-20 -70.27 84.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -130.67 -161.04 1.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.474 ' O ' HD23 ' B' ' 6' ' ' LEU . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.73 ' HA ' HD12 ' B' ' 15' ' ' LEU . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.804 HD22 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 8.8 p-80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 27' ' ' THR . 15.1 t -130.0 59.19 43.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.3 Cg_endo -60.08 92.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.457 2.771 . . . . 0.0 110.153 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.46 101.07 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.51 -179.818 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -63.6 -37.03 78.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.614 -0.933 . . . . 0.0 109.128 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG22 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' HB2' HD11 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.479 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.946 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.788 ' CD2' HD13 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 32.1 t30 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 2' ' ' VAL . 1.4 p90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.419 0.628 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.477 ' O ' ' CE2' ' B' ' 1' ' ' PHE . 0.4 OUTLIER -79.87 107.8 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.367 -0.833 . . . . 0.0 109.187 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.29 77.44 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.15 161.29 16.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.379 -0.826 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.479 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 6' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.638 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 16' ' ' LEU . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 9.5 p-80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.424 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.946 HG22 ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.492 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.6 t -129.0 60.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.2 Cg_endo -65.24 80.71 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.304 2.669 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 28' ' ' PRO . 18.1 mttt -149.23 -172.05 4.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.418 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.671 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -90.36 -39.55 12.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -1.005 . . . . 0.0 109.169 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' B' ' 6' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' C ' ' B' ' 3' ' ' ASN . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD12 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 16' ' ' LEU . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.705 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.89 108.78 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.458 ' C ' HD13 ' A' ' 10' ' ' ILE . 8.5 m120 -88.89 68.3 8.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.546 ' O ' HD23 ' B' ' 6' ' ' LEU . 21.3 m170 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.649 ' O ' HD12 ' B' ' 11' ' ' LEU . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.662 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 19' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.591 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.6 p-80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 14' ' ' ALA . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.597 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 27.6 m -123.15 48.59 2.07 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.5 Cg_endo -60.06 -167.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.177 2.585 . . . . 0.0 110.061 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.421 ' CE ' ' CA ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -165.2 83.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.416 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.411 HG22 ' H ' ' B' ' 30' ' ' THR . 1.2 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.86 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -60.53 -31.39 48.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.889 HD11 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.86 ' CD2' HD13 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.7 ' HE2' HD12 ' A' ' 2' ' ' ILE . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.667 0.746 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.3 149.82 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.065 -1.022 . . . . 0.0 109.454 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.527 ' HB2' ' CG2' ' A' ' 10' ' ' ILE . 2.0 p30 -85.5 114.2 22.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.411 ' HG3' ' C ' ' B' ' 3' ' ' ASN . 5.6 mp0 -132.9 174.12 10.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.596 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' B' ' 24' ' ' PHE . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.615 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 16' ' ' LEU . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.615 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 9.8 p-80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' B' ' 17' ' ' LEU . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 14' ' ' ALA . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.49 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 49.1 p -129.18 60.2 49.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.52 -169.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.328 2.685 . . . . 0.0 109.962 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -111.25 35.11 3.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.214 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.516 -179.904 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -90.47 2.15 7.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.896 -0.767 . . . . 0.0 109.299 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.684 ' HB2' HD11 ' B' ' 11' ' ' LEU . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.926 HD22 HG22 ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' C ' HD11 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.935 ' HB3' HD23 ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.0 132.73 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.664 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.56 ' O ' ' ND2' ' B' ' 3' ' ' ASN . 0.6 OUTLIER -102.26 72.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.382 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.54 167.25 10.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.589 ' O ' HD23 ' B' ' 6' ' ' LEU . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.589 HD23 ' O ' ' B' ' 5' ' ' HIS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.494 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 16' ' ' LEU . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.8 p-80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.406 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.926 HG22 HD22 ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -127.45 59.03 35.14 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.6 Cg_endo -59.52 -170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.432 2.755 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.52 ' HA ' ' CE ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -122.58 16.76 10.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.519 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.571 HD13 ' HE2' ' A' ' 19' ' ' TYR . 7.9 pt -86.78 14.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.518 HG22 ' OH ' ' B' ' 26' ' ' TYR . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.61 ' HB2' HD11 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.408 ' C ' HD23 ' A' ' 16' ' ' LEU . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' B' ' 18' ' ' VAL . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HE2' HD13 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.32 101.11 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.408 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 23.7 p30 -97.64 75.75 2.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.408 ' HG2' ' C ' ' B' ' 3' ' ' ASN . 2.2 mm-40 -129.06 -171.79 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.837 . . . . 0.0 109.487 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.626 ' O ' HD12 ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' B' ' 24' ' ' PHE . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.467 ' O ' ' CE1' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.46 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 16' ' ' LEU . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 9.6 p-80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 17' ' ' LEU . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 16' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' B' ' 12' ' ' VAL . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.54 69.19 42.77 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.08 96.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 109.806 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -119.6 28.43 8.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.667 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.487 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.8 tt . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.305 0.574 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.698 HG22 ' OH ' ' B' ' 26' ' ' TYR . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.67 ' HB2' HD11 ' B' ' 11' ' ' LEU . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' HG12 ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.749 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.829 ' CB ' HG21 ' B' ' 18' ' ' VAL . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.915 ' CB ' HD22 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.525 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.915 HD22 ' CB ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.571 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 14' ' ' ALA . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.133 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 HG22 ' B' ' 18' ' ' VAL . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.944 HD22 HD21 ' B' ' 15' ' ' LEU . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' HG11 ' B' ' 18' ' ' VAL . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 1.133 ' CE2' HD12 ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.554 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' B' ' 15' ' ' LEU . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.547 HG13 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.733 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 16' ' ' LEU . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' ' 17' ' ' LEU . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 14' ' ' ALA . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.7 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.76 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' THR . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.534 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.842 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' C ' HD11 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' HG11 ' B' ' 18' ' ' VAL . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.68 ' CB ' HD22 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.534 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.76 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.428 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.552 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.1 p80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.842 HG22 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.657 HD11 HD23 ' A' ' 16' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.944 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.961 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CB ' HD22 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.727 ' O ' HD23 ' B' ' 6' ' ' LEU . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.727 HD23 ' O ' ' B' ' 5' ' ' HIS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.582 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 16' ' ' LEU . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.944 HG22 ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.045 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.49 HG22 ' OH ' ' B' ' 26' ' ' TYR . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' B' ' 5' ' ' HIS . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.995 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.822 ' HB2' HG21 ' B' ' 18' ' ' VAL . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 1.045 ' CE2' HD12 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.516 ' CE1' HG13 ' A' ' 10' ' ' ILE . 26.9 m80 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.757 HD22 HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.797 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 16' ' ' LEU . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.995 HG22 ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' B' ' 27' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.981 HD12 HD22 ' B' ' 11' ' ' LEU . 13.0 pt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.462 0.649 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.544 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.037 HD11 HG22 ' B' ' 18' ' ' VAL . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.884 ' CB ' HG21 ' B' ' 18' ' ' VAL . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' B' ' 18' ' ' VAL . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.656 ' CE2' HD13 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 1.4 mm100 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.544 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.981 HD22 HD12 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.545 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 1.05 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 1.05 HG23 ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.765 ' CE1' HD11 ' A' ' 2' ' ' ILE . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD23 ' A' ' 16' ' ' LEU . 6.9 tt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.405 0.622 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.512 ' CB ' HG13 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.683 HD11 ' HE1' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.809 HD12 HG22 ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.787 ' CB ' HD22 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 mm100 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.683 ' HE1' HD11 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.511 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.47 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.709 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.81 HD23 ' HB3' ' A' ' 16' ' ' LEU . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.613 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.809 HG22 HD12 ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.27 0.557 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' CYS . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB2' HG21 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CB ' HD22 ' B' ' 15' ' ' LEU . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.487 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.65 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.821 HD22 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.494 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' B' ' 17' ' ' LEU . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 16' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.563 ' CD1' HD11 ' B' ' 15' ' ' LEU . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' B' ' 11' ' ' LEU . 8.5 pt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.645 ' HB2' HD11 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.679 HD21 HG22 ' B' ' 18' ' ' VAL . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.836 HD22 HD21 ' B' ' 15' ' ' LEU . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.648 ' HB2' HD22 ' B' ' 15' ' ' LEU . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.683 ' O ' HD12 ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.512 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.836 HD21 HD22 ' A' ' 16' ' ' LEU . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.9 p80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.696 ' OH ' HG22 ' A' ' 3' ' ' VAL . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.772 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.566 ' HB2' HD11 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 10' ' ' ILE . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 HG22 ' B' ' 18' ' ' VAL . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' CD2' HD13 ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.604 ' HA ' HG11 ' B' ' 18' ' ' VAL . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.699 ' CB ' HD22 ' B' ' 15' ' ' LEU . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.649 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 19' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.741 HG22 HD22 ' A' ' 13' ' ' LEU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.647 HD11 HD23 ' A' ' 16' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.351 0.596 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.749 HG22 ' OH ' ' B' ' 26' ' ' TYR . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.614 ' HB2' HD11 ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.945 HD11 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' HB3' HD11 ' A' ' 2' ' ' ILE . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.938 ' HB3' HD23 ' B' ' 15' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.82 ' CB ' HD22 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 6' ' ' CYS . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.599 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 16' ' ' LEU . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.749 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.169 0.509 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.519 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.881 ' CB ' HD22 ' B' ' 15' ' ' LEU . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.519 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.566 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.628 HG22 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CD2' HG22 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.83 HD11 HD21 ' B' ' 11' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.848 HG22 ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.444 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 ' CE1' ' B' ' 5' ' ' HIS . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.953 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.617 ' HB2' HD22 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.447 ' CE1' HD11 ' A' ' 10' ' ' ILE . 8.5 m80 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.787 ' HB2' HD12 ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.73 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 16' ' ' LEU . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.602 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 14' ' ' ALA . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.848 ' OH ' HG22 ' A' ' 3' ' ' VAL . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 15' ' ' GLN . 3.9 tt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.255 0.55 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HB2' HD11 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.64 ' HB3' HD11 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' B' ' 18' ' ' VAL . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.59 ' CB ' HD22 ' B' ' 15' ' ' LEU . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.399 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' CYS . 23.9 m80 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.567 ' O ' HD12 ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.481 HG13 ' CE2' ' B' ' 24' ' ' PHE . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.908 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' B' ' 17' ' ' LEU . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 14' ' ' ALA . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' B' ' 27' ' ' THR . 9.8 t . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.845 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 2' ' ' ILE . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB2' HD11 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.756 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' C ' HD11 ' A' ' 2' ' ' ILE . 19.3 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.845 ' CD2' HD13 ' A' ' 2' ' ' ILE . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.804 ' CG ' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.348 0.595 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.474 ' O ' HD23 ' B' ' 6' ' ' LEU . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.73 ' HA ' HD12 ' B' ' 15' ' ' LEU . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.804 HD22 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 27' ' ' THR . 15.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG22 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' HB2' HD11 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.479 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.946 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.788 ' CD2' HD13 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 2.1 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.479 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 6' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.638 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 16' ' ' LEU . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.946 HG22 ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.671 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' B' ' 6' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD12 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.705 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.546 ' O ' HD23 ' B' ' 6' ' ' LEU . 38.0 m-70 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.649 ' O ' HD12 ' B' ' 11' ' ' LEU . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.662 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 19' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.591 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.8 p80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 14' ' ' ALA . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.521 HG22 ' O ' ' B' ' 27' ' ' THR . 27.6 m . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.86 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.889 HD11 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.86 ' CD2' HD13 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.7 ' HE2' HD12 ' A' ' 2' ' ' ILE . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.596 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' B' ' 24' ' ' PHE . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 16' ' ' LEU . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' LEU . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 14' ' ' ALA . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.684 ' HB2' HD11 ' B' ' 11' ' ' LEU . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.926 HD22 HG22 ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' C ' HD11 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.935 ' HB3' HD23 ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.589 ' O ' HD23 ' B' ' 6' ' ' LEU . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.589 HD23 ' O ' ' B' ' 5' ' ' HIS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 16' ' ' LEU . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.926 HG22 HD22 ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' B' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.571 HD13 ' HE2' ' A' ' 19' ' ' TYR . 7.9 pt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.456 0.646 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.518 HG22 ' OH ' ' B' ' 26' ' ' TYR . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.61 ' HB2' HD11 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 HG13 ' CE1' ' B' ' 5' ' ' HIS . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.408 ' C ' HD23 ' A' ' 16' ' ' LEU . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' B' ' 18' ' ' VAL . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HE2' HD13 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.401 ' CE1' HG13 ' A' ' 10' ' ' ILE . 66.9 m-70 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.626 ' O ' HD12 ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' B' ' 24' ' ' PHE . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.512 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.46 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 16' ' ' LEU . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 17' ' ' LEU . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 16' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' B' ' 12' ' ' VAL . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.8 tt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -1.032 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.698 HG22 ' OH ' ' B' ' 26' ' ' TYR . 14.3 t -80.54 -35.25 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.459 -0.776 . . . . 0.0 109.238 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.6 -3.39 18.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.94 . . . . 0.0 109.673 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -121.63 -26.56 4.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.769 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' HB2' HD11 ' B' ' 11' ' ' LEU . 80.3 m -104.79 -47.36 4.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 109.861 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' HG12 ' A' ' 3' ' ' VAL . 6.7 t -63.65 -40.4 96.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.926 -1.109 . . . . 0.0 109.282 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 p -77.53 -52.05 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 0.0 109.509 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -115.95 162.73 16.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -84.55 99.63 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.111 -0.993 . . . . 0.0 109.318 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -76.61 -176.35 3.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.782 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.81 177.36 4.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.749 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -76.86 -15.06 59.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 63.0 t80 -75.04 -25.18 58.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.6 -25.91 62.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.702 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.829 ' CB ' HG21 ' B' ' 18' ' ' VAL . 3.5 mt -86.7 -3.85 59.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.1 -1.0 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 60.6 mt-10 -64.56 -39.76 94.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.026 -1.046 . . . . 0.0 109.066 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -64.95 -14.56 60.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.199 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.915 ' CB ' HD22 ' B' ' 15' ' ' LEU . 17.4 m-85 -87.45 20.94 2.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.85 149.47 42.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.412 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.513 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.38 151.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -62.84 88.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -138.08 152.83 49.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -79.55 137.17 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 54.9 mt -98.97 95.12 6.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.415 -0.803 . . . . 0.0 109.827 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 91.8 m -117.77 134.94 54.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.566 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.43 -148.75 37.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 37.0 m -63.79 -11.94 31.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -1.116 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -53.16 -46.03 68.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -60.17 -32.07 70.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.113 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.525 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 42.2 t -65.05 -30.4 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.184 -0.948 . . . . 0.0 108.674 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 4.3 mm-40 -70.34 -18.78 63.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.469 -0.769 . . . . 0.0 109.151 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.13 -19.58 16.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 108.964 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.915 HD22 ' CB ' ' A' ' 19' ' ' TYR . 55.0 mt -76.04 -50.87 13.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.626 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.571 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -60.85 -27.15 67.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.932 . . . . 0.0 109.128 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.61 -32.96 64.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.454 -0.779 . . . . 0.0 109.594 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 14' ' ' ALA . 5.4 t -75.62 -26.19 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.338 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -102.11 -68.73 0.81 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.82 -141.13 16.72 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.84 -26.05 65.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -1.181 . . . . 0.0 109.326 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -55.02 -49.38 71.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.66 -174.54 18.73 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.4 p90 -157.4 166.82 32.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -1.134 . . . . 0.0 109.443 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.576 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 21.1 p90 -118.42 81.13 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.945 . . . . 0.0 109.275 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.8 t80 -69.37 163.19 25.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.707 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.3 t -127.54 57.92 28.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.977 -1.077 . . . . 0.0 110.189 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.4 Cg_endo -62.94 -168.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.332 2.688 . . . . 0.0 110.183 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -150.99 -38.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.31 -0.869 . . . . 0.0 109.697 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.133 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.29 19.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -1.055 . . . . 0.0 109.223 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 t -81.22 -36.01 14.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.707 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -74.83 0.2 16.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.035 . . . . 0.0 109.641 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -126.01 -23.52 3.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.074 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.4 m -100.59 -31.05 11.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.04 -1.037 . . . . 0.0 109.943 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 4.9 t -81.29 -45.99 15.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.33 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -61.45 -37.12 82.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.069 -1.019 . . . . 0.0 109.377 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -146.24 -179.05 6.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 HG13 ' CE1' ' B' ' 5' ' ' HIS . 17.4 mt -84.64 141.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 p -123.02 -168.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.898 . . . . 0.0 109.692 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.6 p -105.62 152.15 23.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD21 HG22 ' B' ' 18' ' ' VAL . 8.1 tp -67.74 -22.81 65.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.0 t80 -57.18 -32.43 66.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -74.74 -28.07 60.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 0.0 109.29 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.944 HD22 HD21 ' B' ' 15' ' ' LEU . 12.8 mt -83.28 -7.4 59.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' HG11 ' B' ' 18' ' ' VAL . 20.0 mt-10 -66.37 -27.19 67.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.109 -0.994 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -66.41 -17.24 64.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.247 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 1.133 ' CE2' HD12 ' A' ' 2' ' ' ILE . 33.2 m-85 -85.91 49.68 1.82 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.799 . . . . 0.0 109.163 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.48 149.06 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.49 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 93.5 t -158.52 116.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.547 ' HB3' HG21 ' A' ' 10' ' ' ILE . 68.6 m-80 -71.76 110.03 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -147.09 156.12 42.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.554 ' CE1' HG13 ' A' ' 10' ' ' ILE . 50.0 m-70 -60.04 127.07 30.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.349 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' B' ' 11' ' ' LEU . 18.8 mt -102.06 92.58 4.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 90.0 m -116.24 154.84 29.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.99 -130.62 39.16 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -89.84 -4.49 57.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -1.13 . . . . 0.0 109.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.1 OUTLIER -57.7 -33.17 68.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.62 HD23 ' HG ' ' B' ' 15' ' ' LEU . 0.5 OUTLIER -68.58 -40.07 80.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.389 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.547 HG13 ' CE2' ' B' ' 24' ' ' PHE . 72.0 t -63.3 -24.31 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.084 -1.01 . . . . 0.0 108.403 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.0 mm-40 -72.98 -27.55 61.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.733 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -93.79 -14.97 25.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 16' ' ' LEU . 18.8 mt -82.0 -43.62 17.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.844 . . . . 0.0 108.847 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.655 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -72.81 -26.53 61.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.968 . . . . 0.0 108.553 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' B' ' 17' ' ' LEU . 21.1 tp -69.58 -39.32 77.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.527 -0.733 . . . . 0.0 109.382 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 14' ' ' ALA . 94.6 t -61.88 -34.05 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.35 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -82.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.38 -114.31 1.52 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.64 -26.11 28.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.519 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -52.4 -79.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.44 -176.12 28.31 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.655 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 40.0 p90 -170.06 133.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.147 -1.208 . . . . 0.0 109.741 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 43.2 p90 -89.5 115.72 27.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.049 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.55 ' CD2' ' HD3' ' B' ' 28' ' ' PRO . 10.5 t80 -91.85 155.08 18.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.58 68.21 52.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.842 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.55 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 4.4 Cg_exo -58.95 116.17 3.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.382 2.721 . . . . 0.0 110.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -116.06 88.86 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.451 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.488 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.7 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -61.07 -37.81 78.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.513 -0.992 . . . . 0.0 108.785 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 85.3 t -37.37 -34.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.296 0.57 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 5.7 tp10 -85.67 43.39 1.03 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.158 -0.963 . . . . 0.0 109.084 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -169.96 -52.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.008 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.76 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -92.53 33.21 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.784 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 19.9 t -141.48 -63.47 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' THR . 2.7 p -64.59 -19.86 65.91 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.84 171.98 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 HG13 ' CE1' ' B' ' 5' ' ' HIS . 18.1 mt -85.41 110.54 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.937 -1.102 . . . . 0.0 109.76 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.69 178.75 7.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.431 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.99 154.86 17.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.842 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -65.7 -9.6 29.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CG ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 t80 -72.62 -39.07 67.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.926 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' C ' HD11 ' A' ' 2' ' ' ILE . 10.6 mm-40 -63.65 -36.9 85.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' CD1' ' A' ' 2' ' ' ILE . 5.2 mt -68.55 -11.97 60.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 109.833 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' HG11 ' B' ' 18' ' ' VAL . 30.8 mt-10 -63.5 -31.7 72.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 108.527 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -22.79 67.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.647 -0.658 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.68 ' CB ' HD22 ' B' ' 15' ' ' LEU . 19.2 m-85 -83.17 13.48 4.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 110.045 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.41 137.1 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.03 -1.044 . . . . 0.0 109.453 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.628 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.527 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 92.3 t -158.8 141.51 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.484 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.421 ' C ' ' HG3' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -70.73 98.41 1.53 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.561 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.471 ' OE1' ' HB ' ' B' ' 2' ' ' VAL . 10.6 mt-30 -140.63 148.67 41.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.41 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.534 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.3 m-70 -65.48 146.09 55.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 109.43 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.76 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mt -123.49 109.6 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.364 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.5 m -136.05 108.19 7.23 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 -125.21 8.5 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.53 59.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . 1.5 m80 -60.75 -40.92 94.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 109.649 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -63.32 -32.84 74.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.0 109.481 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.428 HG13 ' CZ ' ' B' ' 24' ' ' PHE . 24.3 t -64.85 -24.54 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.112 -0.992 . . . . 0.0 108.545 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.552 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 46.6 mt-10 -75.97 -22.35 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.586 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.1 -12.6 19.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 108.818 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 19' ' ' TYR . 51.1 mt -82.51 -50.2 9.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 2.1 p80 -59.66 -33.36 71.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 108.95 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.428 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 63.0 tp -62.03 -32.15 72.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.502 -0.749 . . . . 0.0 109.001 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.842 HG22 ' CD1' ' A' ' 13' ' ' LEU . 44.4 t -71.0 -31.82 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 108.945 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.3 -86.98 0.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.143 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.15 -84.06 1.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.5 OUTLIER -38.35 -66.46 0.26 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.832 -0.804 . . . . 0.0 110.099 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -80.11 -74.92 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.1 -175.87 29.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.9 p90 -136.07 168.88 18.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -1.205 . . . . 0.0 109.65 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.582 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 23.0 p90 -116.61 69.77 0.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.502 -0.749 . . . . 0.0 109.042 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 8.6 t80 -69.42 133.52 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -123.55 70.36 45.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.557 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.1 Cg_endo -61.69 108.7 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.299 2.666 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 3' ' ' VAL . 12.6 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.377 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.657 HD11 HD23 ' A' ' 16' ' ' LEU . 4.4 tt -90.35 -30.24 4.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 46.6 t -51.61 -35.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.268 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.22 37.8 0.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.981 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.24 -51.65 0.14 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.064 -1.022 . . . . 0.0 108.971 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -82.19 -31.41 30.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 109.526 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 13.9 t -80.09 -68.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.25 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -47.79 -52.18 19.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.084 -1.01 . . . . 0.0 109.03 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -121.57 -149.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.408 -0.808 . . . . 0.0 108.856 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' B' ' 3' ' ' ASN . 6.4 mt -118.7 118.63 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.315 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.56 170.24 8.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.786 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 p -98.28 169.81 9.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.829 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.944 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -67.84 -17.62 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.223 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 19.7 t80 -69.57 -23.31 63.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' ' 2' ' ' ILE . 10.5 mm-40 -72.64 -49.96 28.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.818 . . . . 0.0 109.801 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.961 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.0 OUTLIER -61.92 -11.97 15.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.049 -1.032 . . . . 0.0 109.551 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 15.0 mt-10 -62.16 -33.25 74.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.708 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -63.26 -24.51 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.81 . . . . 0.0 109.357 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CB ' HD22 ' B' ' 15' ' ' LEU . 9.1 m-85 -79.71 10.22 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.685 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -102.74 131.44 49.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.058 . . . . 0.0 109.294 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' OD1' ' OXT' ' A' ' 21' ' ' ASN . 20.7 t-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.517 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.227 0.537 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.31 156.89 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.326 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.615 ' HB3' HG21 ' A' ' 10' ' ' ILE . 3.7 m-20 -100.35 114.11 27.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.518 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -146.86 160.33 42.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.727 ' O ' HD23 ' B' ' 6' ' ' LEU . 30.6 m80 -94.26 157.01 16.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.727 HD23 ' O ' ' B' ' 5' ' ' HIS . 4.2 mt -140.51 104.7 4.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.036 -1.04 . . . . 0.0 110.658 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 140.25 52.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.216 -0.928 . . . . 0.0 109.443 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.88 -141.73 22.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' B' ' 12' ' ' VAL . 1.5 p -73.64 -5.56 41.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -1.21 . . . . 0.0 109.393 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -61.85 -53.02 61.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.972 . . . . 0.0 109.436 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' B' ' 6' ' ' LEU . 0.3 OUTLIER -56.74 -29.48 62.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.205 -0.934 . . . . 0.0 109.184 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 46.4 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.5 mt-10 -62.42 -20.63 64.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 109.174 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.582 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.93 -13.09 19.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.34 -0.85 . . . . 0.0 108.98 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.961 HD23 ' HB3' ' A' ' 16' ' ' LEU . 56.3 mt -81.49 -46.44 14.53 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.384 -0.822 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -65.89 -29.59 70.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 54.1 tp -69.91 -14.52 62.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.944 HG22 ' CD1' ' A' ' 13' ' ' LEU . 90.3 t -91.48 -58.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 4.2 m -71.59 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.8 -123.84 7.13 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -72.22 -34.6 68.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -1.156 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -46.83 -46.63 20.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 176.42 25.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 28.9 p90 -157.89 133.26 8.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.379 -1.071 . . . . 0.0 109.532 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 18.2 p90 -85.24 103.75 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 6.4 t80 -87.49 147.03 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.467 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 67.02 69.88 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 2.2 Cg_endo -61.13 90.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.463 2.775 . . . . 0.0 110.239 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.2 83.07 2.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.449 HG23 ' O ' ' B' ' 30' ' ' THR . 9.9 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.045 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -90.84 8.37 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 109.196 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.49 HG22 ' OH ' ' B' ' 26' ' ' TYR . 23.8 t -84.49 -35.54 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.969 -1.082 . . . . 0.0 109.607 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -83.79 -2.28 56.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -120.73 -23.2 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -0.974 . . . . 0.0 109.702 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 9' ' ' SER . 83.0 m -97.0 -70.51 0.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 18.0 t -44.54 -26.99 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 108.716 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' CYS . 1.5 p -78.35 -45.02 23.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.262 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 6' ' ' CYS . 6.2 t -137.53 -136.78 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.328 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' B' ' 5' ' ' HIS . 54.9 mt -118.54 142.31 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.863 -1.148 . . . . 0.0 109.29 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -116.51 -171.7 2.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.934 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -124.14 169.56 11.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.995 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -65.83 -9.42 28.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 3.8 t80 -77.14 -35.49 56.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.837 . . . . 0.0 109.602 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.3 -44.04 84.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.822 ' HB2' HG21 ' B' ' 18' ' ' VAL . 5.3 mt -77.28 -5.74 50.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.976 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.7 mt-10 -64.27 -16.49 62.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.004 -1.06 . . . . 0.0 108.792 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.15 -22.99 28.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.324 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 1.045 ' CE2' HD12 ' A' ' 2' ' ' ILE . 19.8 m-85 -79.85 3.77 18.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.25 138.02 34.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.611 ' O ' HG23 ' B' ' 2' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.611 HG23 ' O ' ' B' ' 1' ' ' PHE . 84.5 t -160.08 132.29 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.402 ' HB3' HD13 ' A' ' 10' ' ' ILE . 7.8 m120 -61.43 107.83 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.642 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.81 152.31 31.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.516 ' CE1' HG13 ' A' ' 10' ' ' ILE . 26.9 m80 -82.71 161.13 22.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 83.2 mt -129.53 98.78 4.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 55.0 m -121.38 159.81 25.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.44 -138.07 47.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.4 22.81 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.637 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 0.2 OUTLIER -85.31 -33.16 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.618 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.757 HD22 HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -61.8 -32.24 72.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.271 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' B' ' 24' ' ' PHE . 57.0 t -65.19 -27.16 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.237 -0.914 . . . . 0.0 108.652 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 9.9 mt-10 -68.66 -23.45 64.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.32 -0.862 . . . . 0.0 108.79 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.797 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.36 -16.37 20.29 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 16' ' ' LEU . 21.7 mt -79.15 -51.24 9.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.134 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.619 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -64.16 -32.17 73.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.18 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 41.7 tp -65.04 -24.37 67.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.329 -0.857 . . . . 0.0 109.165 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.995 HG22 ' CD1' ' A' ' 13' ' ' LEU . 57.6 t -78.11 -18.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.834 . . . . 0.0 109.298 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -87.01 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.74 -118.53 3.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -64.92 -42.89 94.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -1.115 . . . . 0.0 109.43 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -50.11 -67.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.58 170.16 14.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 4.5 p90 -135.49 177.31 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' B' ' 25' ' ' PHE . 9.6 p90 -128.81 81.38 2.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.7 t80 -69.75 169.46 12.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.54 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -131.52 57.99 34.81 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.105 -0.997 . . . . 0.0 109.55 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.54 103.73 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.36 2.707 . . . . 0.0 109.986 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.63 86.25 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.418 179.82 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.981 HD12 HD22 ' B' ' 11' ' ' LEU . 13.0 pt -90.29 -25.03 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 2.6 t -86.0 -34.09 7.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 108.972 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.37 22.79 2.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 108.978 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.65 -55.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 109.592 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' HB2' HD11 ' B' ' 11' ' ' LEU . 21.1 m -69.16 -29.25 67.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.699 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 18.4 t -85.27 -22.89 28.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.001 . . . . 0.0 109.029 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -85.41 -17.93 35.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 108.91 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.3 p -159.47 -159.92 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.544 HG13 ' ND1' ' B' ' 5' ' ' HIS . 0.8 OUTLIER -88.37 151.33 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.894 -1.129 . . . . 0.0 108.763 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -128.61 158.1 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.695 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -94.16 176.54 6.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 0.0 109.169 179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.037 HD11 HG22 ' B' ' 18' ' ' VAL . 13.5 tp -89.04 16.38 7.17 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.014 -1.054 . . . . 0.0 108.577 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 7.8 t80 -101.16 -25.26 14.08 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 111.651 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -80.22 -32.53 38.49 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.721 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.884 ' CB ' HG21 ' B' ' 18' ' ' VAL . 5.8 mt -68.33 -12.8 61.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 108.872 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HG11 ' B' ' 18' ' ' VAL . 25.4 mt-10 -63.71 -28.17 69.71 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.804 -0.56 . . . . 0.0 109.528 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.656 ' CE2' HD13 ' A' ' 2' ' ' ILE . 13.7 m-85 -80.07 1.69 26.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.397 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' B' ' 18' ' ' VAL . 83.7 m -92.18 137.36 32.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.646 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.48 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.32 155.67 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.434 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 44.0 p-10 -94.02 84.11 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 1.4 mm100 -130.54 -160.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.477 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.544 ' ND1' HG13 ' A' ' 10' ' ' ILE . 31.9 m-70 -108.84 125.69 52.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.291 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 44.9 mt -91.56 100.46 13.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 47.1 m -126.04 135.52 51.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.415 -0.803 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.41 -134.55 18.13 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.98 6.29 13.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -1.113 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.03 -31.83 63.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.158 -0.964 . . . . 0.0 109.443 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.981 HD22 HD12 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -73.07 -35.59 66.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 109.428 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' B' ' 15' ' ' LEU . 55.3 t -63.5 -35.04 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.955 . . . . 0.0 108.75 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.545 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 0.9 OUTLIER -59.54 -22.79 62.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 109.117 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 1.05 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.37 -20.63 16.4 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 16' ' ' LEU . 77.6 mt -70.26 -49.75 46.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.399 -0.813 . . . . 0.0 109.45 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.545 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 1.9 p80 -66.29 -32.93 74.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.894 . . . . 0.0 109.109 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 45.6 tp -70.08 -16.3 63.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 109.139 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 1.05 HG23 ' O ' ' B' ' 14' ' ' ALA . 82.1 t -83.63 -38.29 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.3 m -97.79 -60.78 1.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.432 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.42 -121.84 7.31 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.1 -25.46 67.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.4 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -65.02 -47.41 77.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.63 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.73 170.68 30.16 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 9.9 p90 -138.32 153.77 49.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -1.131 . . . . 0.0 109.34 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 1.9 p90 -102.72 75.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.53 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.765 ' CE1' HD11 ' A' ' 2' ' ' ILE . 7.1 t80 -69.66 168.87 13.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.848 . . . . 0.0 109.308 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.1 OUTLIER -128.51 56.35 21.98 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.829 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.1 Cg_endo -60.38 -170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.239 2.626 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -76.0 171.3 14.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.434 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD23 ' A' ' 16' ' ' LEU . 6.9 tt -90.66 -11.7 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.633 -0.922 . . . . 0.0 109.642 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 7' ' ' CYS . 53.7 t -77.67 -37.87 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.832 . . . . 0.0 109.688 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -68.81 -6.96 29.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER -117.35 -22.24 8.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.292 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' B' ' 11' ' ' LEU . 60.9 m -104.76 -53.08 2.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.512 ' CB ' HG13 ' A' ' 3' ' ' VAL . 34.9 t -64.38 -33.55 76.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 35.4 p -93.7 -12.36 29.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . 25.4 m -152.37 -138.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.134 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.683 HD11 ' HE1' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -140.17 131.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 109.215 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 2.7 m -114.89 179.8 3.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 175.76 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.809 HD12 HG22 ' B' ' 18' ' ' VAL . 1.1 mm? -68.82 -17.39 64.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 17.7 t80 -70.97 -23.55 62.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.557 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.2 mm-40 -72.58 -52.28 16.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.733 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.1 mt -63.88 -11.83 31.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 3.4 mt-10 -61.67 -21.95 64.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 0.0 108.771 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.43 -27.45 46.54 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.787 ' CB ' HD22 ' B' ' 15' ' ' LEU . 12.4 m-85 -79.73 8.57 6.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.75 . . . . 0.0 110.061 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.99 145.89 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.446 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.587 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.41 0.624 . . . . 0.0 109.605 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.435 ' H ' HG23 ' B' ' 2' ' ' VAL . 1.8 t -79.96 137.52 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.549 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -77.51 92.36 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.336 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 mm100 -135.03 -177.44 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.331 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.683 ' HE1' HD11 ' A' ' 10' ' ' ILE . 1.9 m-70 -79.83 135.49 36.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.511 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 45.0 mt -106.87 101.74 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.987 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 79.3 m -126.11 139.8 53.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.35 -131.6 24.74 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -78.2 -3.71 44.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.742 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 4.4 m80 -63.92 -36.29 83.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.692 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -76.7 -36.72 57.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.579 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 41.3 t -64.59 -22.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 108.668 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.47 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 17.8 mm-40 -71.33 -26.52 62.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.709 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.46 -20.21 18.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.81 HD23 ' HB3' ' A' ' 16' ' ' LEU . 66.9 mt -70.74 -50.67 33.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.367 -0.833 . . . . 0.0 109.233 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.613 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p80 -69.79 -33.57 72.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.232 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 20.7 tp -63.84 -26.6 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.559 -0.713 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.809 HG22 HD12 ' A' ' 13' ' ' LEU . 53.6 t -72.96 -48.25 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.39 -86.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.87 -118.39 3.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -1.102 . . . . 0.0 109.409 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -55.51 -73.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.3 174.71 13.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 42.8 p90 -160.8 145.43 14.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -1.217 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 30.3 p90 -104.92 93.75 4.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 109.143 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 12.5 t80 -76.83 136.1 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.34 73.71 50.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.256 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.479 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -60.23 117.37 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.355 2.703 . . . . 0.0 110.003 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 101.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.421 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.5 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.518 ' HA2' HG21 ' B' ' 27' ' ' THR . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 19' ' ' TYR . 2.0 tt -90.46 -5.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.368 -1.078 . . . . 0.0 110.032 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' B' ' 26' ' ' TYR . 98.9 t -66.86 -35.86 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.005 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -77.86 4.64 11.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' CYS . 35.1 mt-30 -124.7 -21.54 4.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.005 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' B' ' 11' ' ' LEU . 71.4 m -110.66 -40.32 4.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 12.0 t -77.69 -75.1 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.987 . . . . 0.0 109.349 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' CYS . 18.9 p -43.9 -48.86 8.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.403 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -112.4 -156.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mt -127.04 102.05 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 20.7 p -87.92 -178.23 5.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.567 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.3 170.35 8.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 11.2 tp -68.2 -9.65 48.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.131 -0.981 . . . . 0.0 109.368 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.6 t80 -70.77 -29.31 65.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.246 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -76.62 -25.98 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB2' HG21 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -77.37 -18.34 57.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.03 -1.044 . . . . 0.0 109.529 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 53.3 mt-10 -65.99 -27.77 68.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.185 -0.947 . . . . 0.0 108.851 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.71 -18.96 62.79 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CB ' HD22 ' B' ' 15' ' ' LEU . 14.2 m-85 -84.47 43.04 0.93 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.1 m -122.48 131.41 53.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.068 -1.02 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.548 179.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' B' ' 1' ' ' PHE . 37.9 t80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 1' ' ' PHE . 91.2 t -159.23 135.71 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -60.03 101.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.399 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -149.02 177.9 9.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -75.66 136.01 40.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.013 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 73.1 mt -123.66 95.01 4.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 0.0 110.41 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 0.0 OUTLIER -119.87 168.12 11.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.841 . . . . 0.0 109.432 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.9 -138.14 44.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 13' ' ' GLU . 30.4 p -89.91 14.45 12.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.74 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 24.1 m80 -76.59 -45.2 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -60.35 -35.78 76.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.304 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' B' ' 24' ' ' PHE . 54.1 t -63.66 -33.19 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 0.0 108.925 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.487 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 58.1 mt-10 -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.381 -0.825 . . . . 0.0 109.033 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.65 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.11 -12.93 21.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.029 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.821 HD22 ' CB ' ' A' ' 19' ' ' TYR . 28.4 mt -79.0 -48.32 14.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.165 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.494 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -68.9 -33.53 73.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' B' ' 17' ' ' LEU . 23.9 tp -65.03 -36.37 84.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.736 HG21 ' HB2' ' A' ' 16' ' ' LEU . 97.6 t -73.08 -55.36 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.139 -0.975 . . . . 0.0 109.463 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -78.87 -70.09 0.52 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.68 -130.46 10.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -57.02 -39.05 74.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -46.07 -35.59 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.311 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.73 178.23 42.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 19' ' ' TYR . 29.8 p90 -151.51 134.78 16.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.209 -1.171 . . . . 0.0 109.651 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -89.02 77.45 7.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 108.855 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.563 ' CD1' HD11 ' B' ' 15' ' ' LEU . 9.3 t80 -69.24 163.24 25.42 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.167 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.518 HG21 ' HA2' ' A' ' 1' ' ' GLY . 1.4 t -126.63 58.61 28.53 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 109.55 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.505 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -57.61 -170.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.323 2.682 . . . . 0.0 110.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' B' ' 29' ' ' LYS . 6.7 ttmm -151.27 47.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.473 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' B' ' 11' ' ' LEU . 8.5 pt -84.84 -36.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' OH ' ' B' ' 26' ' ' TYR . 24.3 t -37.82 -33.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.782 -0.574 . . . . 0.0 110.37 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.7 tt0 -85.78 43.05 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.127 -0.983 . . . . 0.0 109.185 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -171.68 -49.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.645 ' HB2' HD11 ' B' ' 11' ' ' LEU . 95.8 m -72.93 -26.19 61.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.571 -0.705 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 10.6 t -89.41 -66.76 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' CYS . 76.6 p -43.83 -27.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.414 -0.804 . . . . 0.0 109.005 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.1 m -153.07 168.54 25.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.982 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.547 HG21 ' HA ' ' B' ' 3' ' ' ASN . 4.3 mt -84.42 100.84 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -79.59 -158.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -115.4 171.44 7.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.482 -0.761 . . . . 0.0 109.172 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.679 HD21 HG22 ' B' ' 18' ' ' VAL . 7.7 tp -74.48 -11.29 60.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.356 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -62.13 -41.54 98.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -36.8 84.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.836 HD22 HD21 ' B' ' 15' ' ' LEU . 2.9 mt -69.21 -19.35 63.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 35.8 mt-10 -67.29 -11.61 58.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 108.814 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.3 -20.58 31.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 109.28 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.648 ' HB2' HD22 ' B' ' 15' ' ' LEU . 18.2 m-85 -82.62 10.73 6.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 143.28 27.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.409 179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.79 141.54 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.479 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.547 ' HA ' HG21 ' A' ' 10' ' ' ILE . 12.6 m120 -71.71 85.93 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' B' ' 3' ' ' ASN . 1.3 mm100 -144.5 132.36 21.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 109.567 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -59.29 135.21 57.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 108.838 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.683 ' O ' HD12 ' B' ' 11' ' ' LEU . 10.2 mt -114.39 101.74 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.27 117.81 25.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.49 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.78 -144.23 16.98 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -62.2 -17.43 58.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -1.097 . . . . 0.0 109.562 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.06 -46.94 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.157 -0.965 . . . . 0.0 109.385 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.29 -30.98 71.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.126 -0.984 . . . . 0.0 109.148 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.442 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 40.1 t -65.46 -21.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 6.2 mm-40 -77.84 -22.6 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.509 -0.744 . . . . 0.0 109.139 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.512 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.42 -15.36 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.191 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.836 HD21 HD22 ' A' ' 16' ' ' LEU . 22.5 mt -82.47 -45.41 14.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.62 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 1.9 p80 -66.53 -35.43 80.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.02 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 37.6 tp -58.32 -38.27 76.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 108.947 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 13' ' ' LEU . 41.1 t -75.26 -31.1 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.303 -0.873 . . . . 0.0 109.038 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -103.74 -99.68 0.3 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.194 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 100.32 -109.39 3.69 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.282 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 2.8 mt-10 -40.37 -69.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.954 . . . . 0.0 110.043 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -52.78 -57.09 11.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.182 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.37 175.02 17.72 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 18.6 p90 -144.61 145.8 31.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -1.057 . . . . 0.0 109.418 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 5.2 p90 -100.65 88.61 3.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.696 ' OH ' HG22 ' A' ' 3' ' ' VAL . 6.6 t80 -70.52 155.2 41.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -135.04 67.18 69.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.02 82.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.41 2.74 . . . . 0.0 109.891 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -151.49 171.62 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.519 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.772 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.43 -42.91 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.488 -1.007 . . . . 0.0 108.904 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' ILE . 61.8 t -34.74 -35.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.41 43.43 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -171.92 -36.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.404 -0.81 . . . . 0.0 109.21 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.566 ' HB2' HD11 ' B' ' 11' ' ' LEU . 33.7 m -89.97 -22.65 21.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.074 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 3.8 t -93.39 -39.21 11.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -39.28 77.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 108.849 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -134.17 -176.15 4.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.0 109.152 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 10' ' ' ILE . 17.9 mt -97.25 83.32 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.316 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.07 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p -105.52 165.02 11.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.451 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.741 HD22 HG22 ' B' ' 18' ' ' VAL . 2.6 mt -70.38 -4.77 23.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.641 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 47.9 t80 -83.47 -27.38 29.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.566 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.84 -44.51 63.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.55 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' CD2' HD13 ' A' ' 2' ' ' ILE . 7.4 mt -66.22 -8.26 23.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.604 ' HA ' HG11 ' B' ' 18' ' ' VAL . 83.5 mt-10 -65.02 -36.55 84.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 108.789 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -19.76 10.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.699 ' CB ' HD22 ' B' ' 15' ' ' LEU . 16.8 m-85 -84.98 46.79 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.624 -0.673 . . . . 0.0 109.346 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.74 138.83 53.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.417 -179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.581 ' HD1' ' H3 ' ' B' ' 1' ' ' PHE . 1.4 p90 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.257 0.551 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.2 125.83 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.341 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -96.91 128.64 44.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.674 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -115.92 -171.29 1.95 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -70.01 135.25 49.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.984 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HD12 ' B' ' 11' ' ' LEU . 13.3 mt -114.91 99.47 7.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.667 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 m -120.98 103.77 9.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.485 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.08 -147.76 18.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -11.66 34.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -62.21 -36.68 82.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -68.65 -31.6 70.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.109 -0.994 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' B' ' 24' ' ' PHE . 46.8 t -65.39 -20.58 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 108.573 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 19.2 mt-10 -77.53 -23.7 50.11 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.649 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.05 -19.12 19.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 108.927 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.699 HD22 ' CB ' ' A' ' 19' ' ' TYR . 34.7 mt -74.83 -50.66 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.847 . . . . 0.0 109.275 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -67.32 -36.74 82.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.18 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' N ' ' CG ' ' B' ' 16' ' ' HIS . 46.0 tp -58.7 -32.07 68.83 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.433 -0.792 . . . . 0.0 109.392 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.741 HG22 HD22 ' A' ' 13' ' ' LEU . 80.7 t -72.35 -45.86 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.189 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -77.37 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.55 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 140.68 -142.72 12.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.0 OUTLIER -69.96 -24.43 63.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -1.108 . . . . 0.0 109.632 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.2 mmt180 -39.98 -68.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.489 -0.757 . . . . 0.0 109.814 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.81 152.79 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -144.81 137.37 26.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -1.114 . . . . 0.0 109.397 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 42.4 p90 -85.62 111.85 20.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.607 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.7 t80 -96.94 175.12 6.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.874 . . . . 0.0 109.035 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.594 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -126.87 51.38 6.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.001 . . . . 0.0 110.119 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.7 Cg_endo -61.42 118.62 5.5 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.072 2.515 . . . . 0.0 109.681 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.93 144.62 43.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.768 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.372 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.647 HD11 HD23 ' A' ' 16' ' ' LEU . 1.5 tt -68.45 -32.88 57.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.534 -0.98 . . . . 0.0 109.455 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.749 HG22 ' OH ' ' B' ' 26' ' ' TYR . 88.2 t -53.11 -34.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -84.45 44.76 1.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.416 -0.802 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -165.86 -38.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 108.892 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.614 ' HB2' HD11 ' B' ' 11' ' ' LEU . 56.8 m -89.2 -48.3 7.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.394 -0.816 . . . . 0.0 109.308 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.3 t -64.58 -38.91 92.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.363 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.34 10.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -124.85 178.06 5.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' B' ' 5' ' ' HIS . 1.1 mt -88.92 87.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 109.623 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -67.47 -177.64 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.07 169.43 9.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.945 HD11 ' CG2' ' B' ' 18' ' ' VAL . 24.5 tp -75.77 -28.48 58.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 3.5 t80 -57.06 -30.51 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' HB3' HD11 ' A' ' 2' ' ' ILE . 13.8 mm100 -65.93 -51.21 60.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.91 . . . . 0.0 109.575 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.938 ' HB3' HD23 ' B' ' 15' ' ' LEU . 0.7 OUTLIER -57.89 -15.13 7.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.54 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 38.9 mt-10 -62.62 -39.39 93.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.021 . . . . 0.0 108.702 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -54.74 -24.97 24.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.868 . . . . 0.0 108.68 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.82 ' CB ' HD22 ' B' ' 15' ' ' LEU . 8.4 m-85 -82.22 44.17 0.85 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.48 147.82 45.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.071 . . . . 0.0 109.222 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.576 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.56 129.76 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.575 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.463 ' O ' ' OD1' ' B' ' 3' ' ' ASN . 17.1 p30 -79.61 87.52 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' B' ' 5' ' ' HIS . 6.6 tp-100 -141.61 154.42 45.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' B' ' 4' ' ' GLN . 47.8 m-70 -68.11 162.92 23.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.676 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 6' ' ' CYS . 84.5 mt -118.5 76.23 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 10' ' ' HIS . 72.8 m -102.66 155.08 18.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.163 -0.961 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.96 -135.85 32.6 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.27 -0.74 55.64 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.388 -1.066 . . . . 0.0 109.678 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' B' ' 7' ' ' CYS . 15.0 m80 -55.84 -50.22 71.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.335 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -56.32 -35.35 67.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.57 HG13 ' CE2' ' B' ' 24' ' ' PHE . 55.1 t -62.92 -36.87 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 108.989 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.32 -17.36 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.599 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.94 -15.09 18.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.014 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 16' ' ' LEU . 89.2 mt -84.23 -44.34 13.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.346 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.608 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -68.12 -35.9 78.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.328 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 39.8 tp -65.26 -25.22 67.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.716 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 13' ' ' LEU . 85.8 t -83.47 -59.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 4.9 m -70.96 -72.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 90.89 -114.82 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' B' ' 22' ' ' ARG . 8.4 mp0 -42.29 -72.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -1.087 . . . . 0.0 109.87 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 21' ' ' GLU . 19.9 mtm180 -43.95 -44.72 7.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.74 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.28 -165.89 19.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.608 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 33.9 p90 -156.37 144.95 20.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -1.115 . . . . 0.0 109.53 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -107.91 90.03 3.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 109.256 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.749 ' OH ' HG22 ' A' ' 3' ' ' VAL . 5.0 t80 -69.98 144.27 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 58.1 m -136.5 66.44 57.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.927 . . . . 0.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.542 ' HG3' ' CD2' ' B' ' 26' ' ' TYR . 2.9 Cg_endo -59.6 -176.14 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.447 2.765 . . . . 0.0 110.163 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -136.12 49.29 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.406 ' OXT' HG22 ' B' ' 30' ' ' THR . 20.5 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -90.58 -0.31 9.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.39 -1.065 . . . . 0.0 109.934 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 59.8 t -72.13 -69.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.0 109.178 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 3' ' ' VAL . 3.7 pt-20 -35.16 -30.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.739 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 3' ' ' VAL . 2.8 mt-30 -89.93 -69.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 110.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.0 OUTLIER -83.32 42.98 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 111.002 -179.017 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 15.3 t -142.2 -66.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.012 . . . . 0.0 108.633 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 p -61.91 -19.31 62.56 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.54 -159.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.519 HG13 ' CE1' ' B' ' 5' ' ' HIS . 43.1 mt -110.26 131.28 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.089 -1.007 . . . . 0.0 109.244 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 12' ' ' SER . 8.8 p -108.99 -157.45 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 109.769 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 p -113.67 161.23 17.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.87 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -71.01 -5.08 28.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.318 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 3.1 t80 -75.76 -38.15 58.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.163 -0.961 . . . . 0.0 110.115 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' ILE . 3.8 mm-40 -63.09 -32.61 74.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.3 mt -78.83 -6.4 55.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 110.098 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 50.1 mt-10 -64.85 -34.14 77.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.949 . . . . 0.0 108.988 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' O ' ' CZ ' ' B' ' 25' ' ' PHE . 10.7 m-20 -75.98 -6.83 52.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.052 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.881 ' CB ' HD22 ' B' ' 15' ' ' LEU . 11.2 m-85 -86.98 19.82 2.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.057 -1.027 . . . . 0.0 109.741 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.28 142.2 43.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.967 -1.083 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' OXT' ' NH1' ' B' ' 22' ' ' ARG . 9.4 t-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.522 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.608 ' HD1' ' H3 ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.502 HG23 ' C ' ' B' ' 1' ' ' PHE . 60.3 t -157.19 123.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.496 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -64.15 92.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 109.666 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -136.41 165.18 26.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.519 ' CE1' HG13 ' A' ' 10' ' ' ILE . 56.9 m-70 -64.75 128.92 37.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.566 ' HB3' ' CA ' ' B' ' 11' ' ' LEU . 13.0 mt -109.93 118.0 35.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.56 -0.713 . . . . 0.0 109.362 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.1 m -144.46 95.38 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.96 -133.77 11.85 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.1 p -63.72 -21.44 66.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -58.17 -56.3 23.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -56.82 -32.13 65.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.089 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.628 HG22 ' CD2' ' B' ' 26' ' ' TYR . 76.7 t -62.91 -36.84 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.086 -1.008 . . . . 0.0 108.661 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 18.2 mt-10 -67.89 -20.07 65.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.457 -0.777 . . . . 0.0 109.132 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -97.32 -11.77 23.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 108.808 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 19' ' ' TYR . 21.7 mt -86.33 -45.79 10.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.21 -0.931 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.3 p80 -66.76 -37.39 84.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 0.0 109.165 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' B' ' 1' ' ' PHE . 42.7 tp -57.58 -40.03 78.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.413 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.557 HG22 HD12 ' A' ' 13' ' ' LEU . 51.7 t -72.85 -34.79 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.392 -0.817 . . . . 0.0 109.581 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.1 m -99.39 -71.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 96.87 -122.43 7.41 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.02 -38.38 85.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -1.181 . . . . 0.0 109.361 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' OXT' ' A' ' 21' ' ' ASN . 9.3 mtm180 -52.75 -26.91 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.82 173.03 49.14 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 36.9 p90 -150.16 136.11 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -1.23 . . . . 0.0 109.58 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' A' ' 18' ' ' ASN . 2.6 p90 -89.24 74.97 7.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.202 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CD2' HG22 ' B' ' 12' ' ' VAL . 10.9 t80 -70.06 139.64 52.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.431 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 76.63 7.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 5.2 Cg_exo -59.01 -170.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.353 2.702 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.61 178.52 4.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 109.571 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.418 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.83 HD11 HD21 ' B' ' 11' ' ' LEU . 0.1 OUTLIER -90.41 -9.84 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -1.154 . . . . 0.0 109.222 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.848 HG22 ' OH ' ' B' ' 26' ' ' TYR . 33.9 t -52.6 -35.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.95 45.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 108.809 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -161.38 -39.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' B' ' 6' ' ' LEU . 0.0 OUTLIER -90.82 -48.07 7.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.97 -61.35 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -50.82 -63.73 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.297 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.444 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 1.8 p -116.87 -97.57 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 ' CE1' ' B' ' 5' ' ' HIS . 50.0 mt -155.62 149.12 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.0 p -132.44 -163.33 1.33 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.5 p -126.34 163.05 24.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 109.203 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' CG2' ' B' ' 18' ' ' VAL . 2.1 mt -62.7 -31.98 72.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 5.1 t80 -54.91 -25.69 30.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.945 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.8 mm100 -70.95 -43.29 68.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.953 ' HB3' HD23 ' B' ' 15' ' ' LEU . 1.1 mt -66.01 -17.19 64.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.611 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.77 -20.41 64.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.212 -0.93 . . . . 0.0 108.827 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -76.19 -28.0 57.11 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.617 ' HB2' HD22 ' B' ' 15' ' ' LEU . 16.2 m-85 -79.53 1.79 24.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.46 -0.775 . . . . 0.0 109.694 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.7 m -95.64 132.5 40.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.386 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.563 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.278 0.561 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.52 147.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' B' ' 3' ' ' ASN . 6.5 p-10 -77.69 79.33 4.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -116.92 -161.41 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.116 -0.99 . . . . 0.0 109.476 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.447 ' CE1' HD11 ' A' ' 10' ' ' ILE . 8.5 m80 -114.92 123.99 50.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.787 ' HB2' HD12 ' B' ' 11' ' ' LEU . 65.1 mt -101.62 76.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.499 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 m -99.15 155.09 17.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.01 -142.25 30.41 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -9.6 53.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -1.107 . . . . 0.0 109.457 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -51.71 -38.84 56.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 2' ' ' ILE . 5.1 tt -65.73 -37.12 85.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' B' ' 24' ' ' PHE . 76.5 t -64.09 -28.22 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.049 -1.032 . . . . 0.0 108.722 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.5 mt-10 -66.26 -25.28 66.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.389 -0.82 . . . . 0.0 108.821 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.73 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -96.51 -15.03 21.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.953 HD23 ' HB3' ' A' ' 16' ' ' LEU . 23.9 mt -79.46 -45.67 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.503 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.602 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -72.85 -18.92 61.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -81.36 -26.25 35.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.372 -0.83 . . . . 0.0 109.665 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 14' ' ' ALA . 61.4 t -82.38 -28.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' B' ' 24' ' ' PHE . 3.7 m -96.6 -23.83 16.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.91 -121.1 25.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.62 -30.93 63.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -1.14 . . . . 0.0 109.579 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -49.77 -23.22 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 109.559 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' B' ' 19' ' ' CYS . . . 74.66 -173.69 51.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 14.1 p90 -165.37 135.98 3.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.237 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.598 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 31.8 p90 -92.79 87.32 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.234 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.848 ' OH ' HG22 ' A' ' 3' ' ' VAL . 4.5 t80 -72.33 173.83 8.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.7 OUTLIER -133.34 59.18 39.38 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.512 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' B' ' 27' ' ' THR . 3.1 Cg_endo -66.52 135.07 37.82 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.351 2.701 . . . . 0.0 109.815 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -114.3 107.52 15.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 15' ' ' GLN . 3.9 tt -90.63 -6.13 10.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.612 -0.934 . . . . 0.0 109.538 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.0 t -76.18 -35.93 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 8' ' ' THR . 50.1 tt0 -71.92 -3.19 21.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -122.61 -20.16 6.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.646 ' HB2' HD11 ' B' ' 11' ' ' LEU . 69.6 m -99.28 -56.48 2.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 5' ' ' HIS . 12.8 t -68.27 -52.99 27.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.413 -0.805 . . . . 0.0 109.803 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 69.8 p -59.17 -57.83 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.964 -1.085 . . . . 0.0 109.458 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -107.4 -146.92 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.43 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.73 85.31 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -66.68 -174.8 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -113.33 167.43 10.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.452 -0.78 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.37 -19.72 65.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.937 . . . . 0.0 109.181 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 51.3 t80 -69.33 -28.48 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.64 ' HB3' HD11 ' A' ' 2' ' ' ILE . 52.2 mm-40 -67.48 -47.08 71.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.312 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' B' ' 18' ' ' VAL . 4.1 mt -60.63 -12.29 9.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.6 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 77.9 mt-10 -61.7 -35.87 79.26 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.263 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.34 -27.96 62.71 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.59 ' CB ' HD22 ' B' ' 15' ' ' LEU . 10.8 m-85 -80.79 35.78 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.661 -0.649 . . . . 0.0 110.98 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.0 m -129.85 128.97 43.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 0.0 109.354 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.284 0.564 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.83 153.75 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -104.79 113.57 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.73 -151.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.473 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 7' ' ' CYS . 23.9 m80 -93.36 138.93 31.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.567 ' O ' HD12 ' B' ' 11' ' ' LEU . 8.0 mt -122.71 103.39 8.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 0.0 110.25 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.09 115.42 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.513 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.14 -138.92 14.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.1 p -74.88 -5.08 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -1.042 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -68.27 -48.08 65.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -64.0 -35.35 80.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.481 HG13 ' CE2' ' B' ' 24' ' ' PHE . 50.5 t -64.1 -34.63 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.084 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 35.5 mt-10 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.023 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.908 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -100.52 -18.68 16.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.265 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' B' ' 26' ' ' TYR . 22.4 mt -75.14 -47.34 29.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.605 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.4 p80 -63.84 -29.34 70.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' B' ' 17' ' ' LEU . 46.7 tp -73.41 -21.4 60.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.827 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.908 HG23 ' O ' ' B' ' 14' ' ' ALA . 10.2 t -85.19 -19.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 5.2 m -108.27 -74.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.98 -118.88 4.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' B' ' 22' ' ' ARG . 0.1 OUTLIER -69.64 -51.91 30.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -1.197 . . . . 0.0 109.896 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' B' ' 21' ' ' GLU . 6.1 mtt180 -42.01 -41.3 2.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.886 . . . . 0.0 109.874 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.65 -178.35 39.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.605 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 13.1 p90 -143.37 157.3 44.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -1.117 . . . . 0.0 109.575 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.0 88.39 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.227 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 4.1 t80 -69.65 167.28 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.319 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 9.8 t -129.0 54.6 14.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.146 -0.971 . . . . 0.0 109.922 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.0 OUTLIER -61.66 96.66 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.181 2.587 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 6.6 pttp -118.26 140.52 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.66 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.845 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.01 -33.55 36.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.448 -1.03 . . . . 0.0 109.213 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.462 ' C ' ' O ' ' A' ' 2' ' ' ILE . 59.2 t -38.47 -34.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.702 -0.624 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 2' ' ' ILE . 1.3 tp10 -85.82 48.43 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 108.962 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.41 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -178.49 -33.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.53 -0.731 . . . . 0.0 109.125 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB2' HD11 ' B' ' 11' ' ' LEU . 13.8 m -96.64 -29.97 13.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.369 -0.832 . . . . 0.0 109.172 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 6' ' ' LEU . 11.5 t -92.48 -26.67 17.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.327 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.427 ' O ' ' OG ' ' A' ' 9' ' ' SER . 51.9 p -75.01 -7.85 54.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 109.724 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 8' ' ' THR . 7.8 m -165.97 -154.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.517 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 4' ' ' GLN . 0.9 OUTLIER -85.09 100.13 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.539 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 6' ' ' LEU . 41.9 t -55.57 156.33 4.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 43.5 p -118.58 174.61 6.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.173 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.756 ' CD1' HG22 ' B' ' 18' ' ' VAL . 1.4 mm? -88.82 8.3 29.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 7.2 t80 -100.23 -38.74 8.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.531 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' C ' HD11 ' A' ' 2' ' ' ILE . 19.3 mt-30 -64.05 -35.86 82.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 109.797 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.845 ' CD2' HD13 ' A' ' 2' ' ' ILE . 3.2 mt -77.55 -7.78 56.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.71 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 11.8 mt-10 -68.18 -17.48 64.34 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -87.5 -12.03 47.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.326 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.804 ' CG ' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -81.13 12.54 3.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 110.299 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 168.03 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 109.299 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.411 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' B' ' 1' ' ' PHE . 12.1 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.544 HG12 ' H ' ' B' ' 3' ' ' ASN . 3.9 t -103.65 171.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.544 ' H ' HG12 ' B' ' 2' ' ' VAL . 1.9 m-20 -70.27 84.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -130.67 -161.04 1.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.474 ' O ' HD23 ' B' ' 6' ' ' LEU . 79.9 m80 -117.01 153.32 32.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.493 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 11' ' ' CYS . 54.2 mt -122.0 81.04 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 83.4 m -113.56 116.66 29.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.617 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.72 -135.8 12.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.04 -6.59 59.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.421 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.24 -27.36 69.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.387 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -70.58 -37.32 73.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.433 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.73 ' HA ' HD12 ' B' ' 15' ' ' LEU . 48.3 t -63.81 -37.88 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.051 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.469 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.0 OUTLIER -63.51 -18.3 63.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.94 . . . . 0.0 109.076 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.62 -19.03 17.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.34 -0.85 . . . . 0.0 108.985 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.804 HD22 ' CG ' ' A' ' 19' ' ' TYR . 39.5 mt -75.96 -48.79 19.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.91 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.228 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 29.9 tp -66.21 -18.14 65.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.401 -0.812 . . . . 0.0 109.481 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 14' ' ' ALA . 8.4 t -91.41 -20.35 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -113.25 -93.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.968 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.36 -113.7 4.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 20' ' ' GLY . 3.5 mm-40 -42.06 -63.26 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -1.056 . . . . 0.0 109.742 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.86 -69.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.1 -173.37 16.21 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 38.0 p90 -159.69 166.49 30.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.13 -1.218 . . . . 0.0 109.66 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 4.9 p90 -130.67 99.55 4.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.539 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.1 t80 -69.86 167.39 17.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 27' ' ' THR . 15.1 t -130.0 59.19 43.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.3 Cg_endo -60.08 92.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.457 2.771 . . . . 0.0 110.153 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.46 101.07 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 109.4 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.51 -179.818 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -63.6 -37.03 78.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.614 -0.933 . . . . 0.0 109.128 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG22 ' OH ' ' B' ' 26' ' ' TYR . 84.8 t -40.84 -35.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 109.974 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 mm-40 -85.32 46.18 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.4 mp0 -171.31 -36.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.805 . . . . 0.0 108.998 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' HB2' HD11 ' B' ' 11' ' ' LEU . 37.5 m -97.08 -41.9 8.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.303 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 19.1 t -70.45 -29.97 66.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -89.97 -30.94 17.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.187 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -135.31 -142.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.075 179.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.479 HG13 ' CE1' ' B' ' 5' ' ' HIS . 79.4 mt -135.94 103.79 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.08 . . . . 0.0 109.434 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.8 m -75.82 -168.46 0.88 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 p -118.15 -178.07 3.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.946 ' CD1' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -76.89 2.27 15.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 109.343 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.1 t80 -97.8 -25.45 15.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.531 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -72.59 -44.41 62.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 109.853 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.788 ' CD2' HD13 ' A' ' 2' ' ' ILE . 8.5 mt -70.48 -5.47 28.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.2 mt-10 -65.08 -32.66 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 108.839 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.44 -18.3 63.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.025 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.9 m-85 -84.37 47.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.665 -0.647 . . . . 0.0 109.786 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.79 149.24 44.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' OXT' ' NH2' ' B' ' 22' ' ' ARG . 2.1 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.498 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 2' ' ' VAL . 1.4 p90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.419 0.628 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.477 ' O ' ' CE2' ' B' ' 1' ' ' PHE . 0.4 OUTLIER -79.87 107.8 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.367 -0.833 . . . . 0.0 109.187 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.29 77.44 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.15 161.29 16.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.379 -0.826 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.479 ' CE1' HG13 ' A' ' 10' ' ' ILE . 11.5 m80 -78.1 177.5 8.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 6' ' ' CYS . 66.5 mt -141.97 97.58 3.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 69.7 m -123.45 128.58 50.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.429 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.02 -150.02 30.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -61.61 -15.39 38.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.29 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -55.64 -28.93 58.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.41 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -77.5 -32.4 54.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.086 -1.009 . . . . 0.0 109.305 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 26.6 t -65.06 -25.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.141 -0.974 . . . . 0.0 108.431 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 2.2 mt-10 -68.39 -25.44 65.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.376 -0.828 . . . . 0.0 108.865 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.638 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -98.03 -18.1 18.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 16' ' ' LEU . 70.5 mt -75.42 -49.23 19.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.446 -0.783 . . . . 0.0 109.338 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' CB ' ' CE1' ' B' ' 24' ' ' PHE . 2.1 p80 -69.1 -35.13 76.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 0.0 109.074 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 46.8 tp -59.42 -28.14 66.66 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.208 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.946 HG22 ' CD1' ' A' ' 13' ' ' LEU . 97.1 t -83.29 -48.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.183 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.09 -85.44 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.317 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 78.79 -94.29 1.31 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.7 OUTLIER -39.47 -68.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.746 -0.855 . . . . 0.0 109.925 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.469 ' NH2' ' OXT' ' A' ' 21' ' ' ASN . 7.6 mmm180 -64.27 -33.59 76.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 177.85 34.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.556 ' CE1' ' CB ' ' B' ' 16' ' ' HIS . 15.1 p90 -148.87 159.65 43.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -1.153 . . . . 0.0 109.68 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.592 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 18.6 p90 -114.17 85.08 2.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.274 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 5.2 t80 -69.79 157.53 37.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.085 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.492 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 1.6 t -129.0 60.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.285 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' B' ' 27' ' ' THR . 2.2 Cg_endo -65.24 80.71 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.304 2.669 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 28' ' ' PRO . 18.1 mttt -149.23 -172.05 4.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.418 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.671 HG21 HD21 ' B' ' 11' ' ' LEU . 0.0 OUTLIER -90.36 -39.55 12.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -1.005 . . . . 0.0 109.169 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 72.8 t -44.69 -35.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 3.2 tp10 -85.14 45.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.6 mt-30 -174.32 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 109.119 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' HD12 ' B' ' 6' ' ' LEU . 63.4 m -69.47 -37.28 77.22 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 0.0 109.54 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 7.1 t -76.59 -73.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.391 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 7' ' ' CYS . 28.1 p -42.58 -56.78 2.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.676 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' GLN . 55.7 m -120.16 -178.0 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' C ' ' B' ' 3' ' ' ASN . 32.0 mt -88.81 154.19 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.6 p -136.51 -164.61 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.668 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 p -112.75 167.92 10.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.339 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD12 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -76.04 -0.16 20.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 109.673 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 18.3 t80 -82.44 -25.95 33.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -71.75 -41.81 67.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 16' ' ' LEU . 1.9 mt -70.66 -9.54 57.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.591 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 16.6 mt-10 -66.66 -21.83 66.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 108.841 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -78.1 -17.49 56.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.337 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.705 ' CG ' HD22 ' B' ' 15' ' ' LEU . 12.3 m-85 -81.11 3.6 22.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.768 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -100.71 130.84 46.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 109.383 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.53 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.89 108.78 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.458 ' C ' HD13 ' A' ' 10' ' ' ILE . 8.5 m120 -88.89 68.3 8.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.546 ' O ' HD23 ' B' ' 6' ' ' LEU . 38.0 m-70 -102.27 155.21 18.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.435 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.649 ' O ' HD12 ' B' ' 11' ' ' LEU . 21.7 mt -124.49 90.3 3.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.825 . . . . 0.0 109.596 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 142.02 50.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.54 -137.49 21.8 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 36.5 p -76.0 -8.41 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -58.56 -41.77 86.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -66.82 -35.98 81.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.585 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 39.7 t -63.98 -22.11 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.138 -0.976 . . . . 0.0 108.62 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.28 -26.7 60.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.662 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.46 -9.88 22.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.479 -0.763 . . . . 0.0 109.178 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 19' ' ' TYR . 37.7 mt -83.67 -44.56 14.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.35 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.591 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.8 p80 -73.15 -35.92 66.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 36.8 tp -61.42 -39.55 91.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.421 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 14' ' ' ALA . 89.5 t -68.19 -32.36 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.468 -0.77 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 m -96.37 -73.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.84 -123.61 6.83 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' B' ' 22' ' ' ARG . 19.2 tp10 -67.37 -40.55 85.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -1.134 . . . . 0.0 109.39 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' B' ' 21' ' ' GLU . 1.7 mtp180 -44.25 -57.91 3.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.71 171.93 18.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 22.0 p90 -145.79 154.28 41.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.143 . . . . 0.0 109.412 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -104.06 83.55 2.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 7.9 t80 -69.42 173.26 6.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.15 -0.969 . . . . 0.0 109.229 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.597 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 27.6 m -123.15 48.59 2.07 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.5 Cg_endo -60.06 -167.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.177 2.585 . . . . 0.0 110.061 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.421 ' CE ' ' CA ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -165.2 83.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.416 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.411 HG22 ' H ' ' B' ' 30' ' ' THR . 1.2 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.86 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -60.53 -31.39 48.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 97.0 t -38.79 -32.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.457 0.646 . . . . 0.0 109.385 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 2' ' ' ILE . 2.8 mt-10 -85.51 41.6 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 108.909 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -159.13 -49.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -89.09 -36.51 15.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.147 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 10.7 t -67.23 -56.47 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.982 -1.074 . . . . 0.0 108.893 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -54.39 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 6' ' ' CYS . 3.7 m -105.03 -156.31 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' B' ' 5' ' ' HIS . 61.0 mt -102.46 111.74 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.849 -1.157 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -83.52 170.2 14.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 159.86 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 109.962 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.889 HD11 HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -64.51 -28.14 69.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.784 . . . . 0.0 109.202 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 93.7 t80 -62.26 -22.0 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.77 -49.21 40.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.846 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.86 ' CD2' HD13 ' A' ' 2' ' ' ILE . 6.5 mt -68.34 -5.97 21.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 109.938 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 14' ' ' TYR . 37.1 mt-10 -66.19 -25.76 67.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.039 -1.038 . . . . 0.0 108.888 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -71.88 -17.72 62.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.7 ' HE2' HD12 ' A' ' 2' ' ' ILE . 14.5 m-85 -82.8 12.8 4.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.095 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.93 143.5 29.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.186 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.53 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.667 0.746 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.3 149.82 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.065 -1.022 . . . . 0.0 109.454 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.527 ' HB2' ' CG2' ' A' ' 10' ' ' ILE . 2.5 p-10 -85.5 114.2 22.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.341 -0.849 . . . . 0.0 109.488 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.411 ' HG3' ' C ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER -132.9 174.12 10.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.596 ' CE1' HG13 ' A' ' 10' ' ' ILE . 23.3 m-70 -71.55 126.57 30.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.772 ' HB2' HD12 ' B' ' 11' ' ' LEU . 12.1 mt -105.88 85.76 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -110.01 118.82 37.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.838 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.18 -147.41 18.56 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -73.2 -4.38 32.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -1.161 . . . . 0.0 109.591 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -30.46 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.76 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -68.25 -29.45 68.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.101 -0.999 . . . . 0.0 109.454 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' B' ' 24' ' ' PHE . 78.5 t -67.71 -25.13 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.025 -1.047 . . . . 0.0 108.474 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 1.2 mm-40 -73.08 -18.44 61.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -99.12 -23.34 15.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 16' ' ' LEU . 97.1 mt -73.54 -57.38 4.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.115 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -56.25 -32.69 64.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 108.569 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' LEU . 22.8 tp -62.76 -38.15 89.46 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 14' ' ' ALA . 3.5 t -73.96 -20.62 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.525 -0.734 . . . . 0.0 109.098 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -119.56 -84.25 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.539 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.17 -117.47 5.17 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -51.0 -31.92 19.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.104 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -71.34 -42.14 68.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 0.0 109.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.7 162.47 36.01 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.6 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 11.5 p90 -143.84 156.96 44.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.132 -1.216 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.0 82.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.616 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 10.0 t80 -69.78 166.02 20.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 108.7 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.49 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 49.1 p -129.18 60.2 49.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' B' ' 27' ' ' THR . 1.3 Cg_endo -62.52 -169.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.328 2.685 . . . . 0.0 109.962 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -111.25 35.11 3.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.214 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.516 -179.904 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.677 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -90.47 2.15 7.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.896 -0.767 . . . . 0.0 109.299 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 98.5 t -86.45 -37.75 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HG3' ' OE1' ' A' ' 5' ' ' GLN . 8.4 pt-20 -75.45 -0.12 18.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 109.507 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -125.32 -28.77 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.108 -0.995 . . . . 0.0 109.784 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.684 ' HB2' HD11 ' B' ' 11' ' ' LEU . 78.1 m -94.62 -46.07 7.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.976 . . . . 0.0 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 5.4 t -68.84 -41.96 77.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.151 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.2 p -68.35 -54.19 19.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.317 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' CYS . 24.4 p -115.64 -142.65 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.846 . . . . 0.0 109.261 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.45 94.38 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.0 p -72.48 -173.82 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.747 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -114.2 168.86 9.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.444 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.926 HD22 HG22 ' B' ' 18' ' ' VAL . 6.2 mt -60.98 -28.22 68.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 2.8 t80 -57.01 -33.23 66.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' C ' HD11 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -69.3 -45.04 70.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 109.546 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.935 ' HB3' HD23 ' B' ' 15' ' ' LEU . 3.2 mt -69.96 -8.28 47.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 47.3 mt-10 -64.78 -24.8 67.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.995 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -20.02 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.417 -0.802 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' B' ' 26' ' ' TYR . 18.0 m-85 -80.3 3.65 20.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 137.45 37.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.307 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.532 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.0 132.73 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.664 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' B' ' 3' ' ' ASN . 11.4 p30 -102.26 72.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.382 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.54 167.25 10.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.589 ' O ' HD23 ' B' ' 6' ' ' LEU . 16.4 m80 -81.9 167.4 19.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.589 HD23 ' O ' ' B' ' 5' ' ' HIS . 62.9 mt -130.27 84.03 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.339 -0.851 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 98.7 m -113.46 124.9 53.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.05 -144.2 19.24 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -8.36 51.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -1.151 . . . . 0.0 109.449 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -59.02 -32.04 69.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.652 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -71.28 -36.44 71.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.968 . . . . 0.0 109.299 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.611 ' CG2' ' CD2' ' B' ' 26' ' ' TYR . 37.4 t -63.92 -28.25 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.305 -0.872 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 29.8 mm-40 -70.79 -22.39 62.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 109.088 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.8 -14.34 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.815 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.935 HD23 ' HB3' ' A' ' 16' ' ' LEU . 76.7 mt -79.94 -49.9 11.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 109.351 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -63.76 -33.35 75.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.205 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' B' ' 16' ' ' HIS . 59.8 tp -60.96 -23.48 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.531 -0.73 . . . . 0.0 109.348 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.926 HG22 HD22 ' A' ' 13' ' ' LEU . 53.1 t -81.34 -53.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 -76.36 0.42 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.5 -118.98 6.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.03 -34.19 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -1.106 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -58.69 -39.44 80.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.37 152.87 23.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' B' ' 16' ' ' HIS . 5.0 p90 -132.08 155.65 47.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.189 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' B' ' 25' ' ' PHE . 28.4 p90 -103.49 70.71 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.602 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' B' ' 15' ' ' LEU . 24.9 t80 -69.71 171.74 8.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.147 -0.97 . . . . 0.0 109.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' B' ' 28' ' ' PRO . 0.2 OUTLIER -127.45 59.03 35.14 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.095 -1.003 . . . . 0.0 109.522 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' CD2' ' B' ' 26' ' ' TYR . 2.6 Cg_endo -59.52 -170.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.432 2.755 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.52 ' HA ' ' CE ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -122.58 16.76 10.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.318 -0.864 . . . . 0.0 109.372 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.519 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.571 HD13 ' HE2' ' A' ' 19' ' ' TYR . 7.9 pt -86.78 14.36 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.518 HG22 ' OH ' ' B' ' 26' ' ' TYR . 3.6 t -82.26 -34.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.802 . . . . 0.0 109.401 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -0.14 18.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.17 -0.956 . . . . 0.0 109.462 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -26.4 4.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.746 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.61 ' HB2' HD11 ' B' ' 11' ' ' LEU . 1.7 m -94.45 -29.51 14.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 3.6 t -86.29 -52.98 5.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.054 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -47.03 -35.69 7.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.417 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' CYS . 17.1 m -146.39 177.89 8.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 HG13 ' CE1' ' B' ' 5' ' ' HIS . 22.4 mt -85.05 99.75 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 0.0 109.518 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.41 -146.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 p -133.72 164.08 28.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.804 -1.185 . . . . 0.0 109.856 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -71.32 -5.39 32.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -0.843 . . . . 0.0 109.603 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 24.1 t80 -75.77 -31.21 59.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.283 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.408 ' C ' HD23 ' A' ' 16' ' ' LEU . 4.4 mm-40 -67.79 -26.42 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.803 ' HB2' HG21 ' B' ' 18' ' ' VAL . 1.2 mt -79.1 -14.65 59.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.809 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 14' ' ' TYR . 37.5 mt-10 -65.49 -20.9 66.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -77.18 -20.5 55.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.626 -0.671 . . . . 0.0 109.633 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' HE2' HD13 ' A' ' 2' ' ' ILE . 13.6 m-85 -81.44 7.26 12.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 110.19 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.3 m -99.95 129.95 46.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.498 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.515 -179.846 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.32 101.11 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.408 ' C ' ' HG2' ' B' ' 4' ' ' GLN . 23.7 p30 -97.64 75.75 2.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.408 ' HG2' ' C ' ' B' ' 3' ' ' ASN . 2.2 mm-40 -129.06 -171.79 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.837 . . . . 0.0 109.487 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.401 ' CE1' HG13 ' A' ' 10' ' ' ILE . 66.9 m-70 -87.4 136.68 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.282 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.626 ' O ' HD12 ' B' ' 11' ' ' LEU . 12.5 mt -117.5 95.68 5.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m -111.28 146.94 36.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.54 -136.39 22.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -7.8 59.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -1.172 . . . . 0.0 109.43 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -53.82 -34.66 59.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.069 -1.019 . . . . 0.0 109.382 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -69.63 -33.71 73.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.376 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' B' ' 24' ' ' PHE . 51.0 t -63.71 -28.9 45.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.21 -0.931 . . . . 0.0 108.867 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.512 ' O ' ' CD2' ' B' ' 16' ' ' HIS . 3.5 mt-10 -66.72 -24.78 66.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.187 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.46 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -101.36 -14.81 17.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.168 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 16' ' ' LEU . 18.0 mt -79.13 -41.65 28.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.883 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 2.0 p80 -69.05 -32.22 71.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 109.764 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 17' ' ' LEU . 34.9 tp -64.91 -39.65 93.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 16' ' ' LEU . 50.8 t -70.91 -25.11 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 22' ' ' ARG . 7.1 m -110.72 5.79 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.797 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 16' ' ' HIS . . . 42.21 -120.82 2.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -90.05 -19.97 23.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.0 109.631 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' B' ' 21' ' ' GLU . 8.7 mmt180 -40.16 -27.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 109.749 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 90.14 151.32 25.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' B' ' 12' ' ' VAL . 22.5 p90 -147.42 130.37 16.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 8.3 p90 -84.91 98.13 10.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.026 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.626 ' CD2' ' CG2' ' B' ' 12' ' ' VAL . 8.8 t80 -74.66 151.14 39.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.54 69.19 42.77 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.08 96.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 109.806 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -119.6 28.43 8.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.667 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.487 179.967 . . . . . . . . 0 0 . 1 stop_ save_